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THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 
AND ACID-BASE TRANSPORTERS OF THE MURINE DUODENUM 
 
Janet Elizabeth Simpson 
Dr. Lane Clarke, Dissertation Supervisor 
ABSTRACT 
 
 
The alkaline mucus barrier of the duodenum plays an important role in protecting 
the epithelium from acidic chyme entering from the stomach.  Active HCO3- secretion 
involves the apical membrane activities of the cystic fibrosis transmembrane conductance 
regulator (CFTR) Cl- channel, the protein that is defective in cystic fibrosis, and Cl-
/HCO3- exchangers.  Under basal, non-stimulated conditions, studies of CF patients and 
mouse models indicate that bicarbonate secretion by anion exchange predominates.  In 
addition, basal bicarbonate secretion is reduced in the CF duodenum, but the specific 
pathophysiology of the deficiency has yet to be elucidated.  Therefore, the goal of this 
research is to investigate basal bicarbonate secretion in the upper duodenal villous 
epithelium of the CF mouse and to determine the identity of the anion exchanger(s) that 
participates in this process.  Under basal conditions, our studies reveal that Cl- channel 
activity by CFTR facilitates apical membrane Cl-in/HCO3-out exchange by providing a Cl- 
‘leak’ and is responsible for the reduced rate of Cl-/HCO3- exchange in the murine CF 
intestine.  Using mice with gene-targeted deletions of the apical membrane Cl-/HCO3- 
exchangers PAT-1, DRA, and AE4, PAT-1 was found to be the major Cl-/HCO3- 
exchanger of the upper villus of the duodenum.  These studies also revealed a propensity 
 xiv
for PAT-1 to act as a base-importer (i.e., Cl-out/HCO3-in) in native villous epithelium.  The 
ability of PAT-1 to function as a base-importer may be physiologically relevant as the 
upper villous epithelium of the duodenum is exposed to acid challenge not only from 
gastric effluent, but also from H+ influx during nutrient absorption, e.g., PEPT1-mediated 
absorption.  Furthermore, PAT-1 has been shown to interact with carbonic anhydrase II 
(CAII), the most widely expressed isozyme of the small intestine.  Examination of CAII 
and PAT-1 (-) mice indicated that both PAT-1 and CAII contribute to pHi regulation 
during peptide absorption.  PAT-1 was found to principally function in Cl-out /HCO3-in 
exchange during the dipeptide absorption, thus allowing for transmembrane movement of 
membrane-impermeant HCO3-.  Taken together, these data indicate the existence of a 
HCO3- metabolon whereby PAT-1 and CAII mediate HCO3- uptake during H+/peptide 
transport to minimize intracellular acidification and sustain peptide absorption.   
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Chapter 1 
INTRODUCTION AND BACKGROUND 
 
 
Gastrointestinal Physiology and Morphology 
 The gastrointestinal tract is responsible for the digestion and absorption of 
nutrients, absorption/secretion of electrolytes and water to help regulate fluid volume, 
sequestration of feces, and defecation.  The intestine can be divided into two main 
portions, the small and large intestine.  The functional unit of the small intestine is the 
crypt-villus axis (Figure 1.1), which consists of crypts, a maturation zone, and villi.  The 
epithelial cells of the crypt are undifferentiated and mature as they migrate from villus to 
the tips (66).  Within the crypt-villus axis, there is a gradient for secretion and absorption 
where secretion chiefly occurs in the crypts and absorption in the villi (31;39;76).  The 
small intestine can be divided further into the duodenum, jejunum, and ileum (Figure 
1.2), and it principally functions in luminal digestion and absorption of carbohydrates, 
proteins, and fats and also in water and electrolyte transport (31).  In addition, the 
duodenum, which is located just distal to the stomach, provides an alkaline mucus barrier 
to help protect the intestinal epithelium from the acidic chyme exiting the stomach (36).  
The large intestine, which is devoid of villi, is composed of surface epithelia and 
numerous crypts which extend deep into the mucosa containing epithelial, mucous, and 
endocrine cells.  Migration of epithelial cells is similar in the large intestine with 
undifferentiated cells migrating from the lower half of the crypts towards the surface.  
Anatomically, the large intestine is divided into the cecum, colon, and rectum, and is  
Villus
Crypt
 
Figure 1.1.  Photomicrograph showing a cross-section of a crypt and villus (20X 
magnification stained with toluidine blue). 
 
Duodenum
Jejunum
Ileum
Cecum
Proximal LI
Distal LI
 
Figure 1.2.  Photograph showing the murine gastrointestinal tract and its major 
anatomical structures. 
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primarily responsible for the extraction of water and electrolytes from the lumen, 
microbial fermentation, storage of feces, and defecation (11). 
 Enterocytes are simple columnar epithelial cells that cover the surface of the 
intestine in a single layer that is periodically interrupted by mucus-secreting goblet cells 
(66).  The enterocytes are connected by tight junctions and serve as a barrier to the 
macromolecular contents of the intestinal lumen.  Through the tight junctions, the 
intestinal epithelium allows for the passage of water and some electrolytes and nutrients 
paracellularly (66).  The enterocytes themselves are polarized with distinct apical (a.k.a., 
luminal, mucosal) and basolateral (a.k.a., blood, serosal) membranes that permit 
transcellular ion transport processes.  A cell model of a small intestinal villous enterocyte 
is depicted in Figure 1.3.  Ion transporters localized to the apical membrane include Cl-
/HCO3- exchangers (e.g., slc26a3, down-regulated in adenoma, DRA; slc26a6, putative 
anion transporter 1, PAT-1; and slc4a9, anion exchanger isoform 4, AE4), Na+/H+ 
exchangers (e.g., NHE2 and NHE3), nutrient transporters (e.g., the H+/peptide 
cotransporter PEPT1 and Na+ coupled nutrient transporters), and anion channels such as 
the cystic fibrosis transmembrane conductance regulator (CFTR) (31).  The transporters 
of the apical membrane primarily allow for vectorial movement of electrolytes and 
nutrients from the intestinal lumen (31;88).  Carbonic anhydrases (CAs) are expressed 
both extra- and intracellularly and reversibly catalyze the conversion of CO2 and H2O to 
H+ and HCO3- (95).  The basolateral transporters include the Na+/K+ ATPase, K+ 
channels, Na+/K+/2Cl- cotransporter (NKCC1), Na+-HCO3- cotransporters (NBCs), 
Na+/H+ exchanger isoform 1 (NHE1),  and the Cl-/HCO3- exchanger AE2 (31).  The 
  
 
Lumen (mucosal, apical) 
3Na+
2K+
H+
Na+
NHE1
Na+ HCO3-
NBC
CO2
H2O
HCO3-
H+
C.A.
HCO3-
AE2
Cl-Na+K+2Cl-
NKCC1
Cl-
HCO3-
Cl
CFTR
HCO
Cl-
NHE
H+
Na+ dipeptide
tripeptideH+
Pept1
 
Blood (serosal, basolateral) 
 
 
Figure 1.3.  Generic model of an intestinal villous epithelial cell.  Relevant ion 
transporters are labeled. 
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principal functions of the basolateral transporters are to regulate cell volume and pH 
regulation, establish membrane potential, and take up ions for transcellular secretion. 
 
Cystic Fibrosis 
 Cystic fibrosis (CF) is an autosomal recessive disease that is the most common 
lethal genetic disorder in the Caucasian population (27).  CF affects approximately 
30,000 children and adults in the United States with the median age of survival being 
36.8 years according to a recent survey by the Cystic Fibrosis Foundation, and it is 
estimated that approximately 5% of the population are clinically silent heterozygous 
carriers (2).  CF is caused by a mutation in CFTR, a cyclic nucleotide-activated anion 
channel that is expressed in the apical membrane of epithelial cells in the airways, 
pancreatic ducts, intestine, salivary and sweat ducts, and gallbladder (7;86).  As result, 
there is a loss of anion secretion principally Cl- through CFTR as well as the loss of direct 
and indirect regulatory influence over many transepithelial electrolyte transport processes 
including HCO3- secretion (25;43;45;46;96) and NaCl absorption (6).  In CF patients, 
over 1400 mutations of CFTR have been identified (3); however, the most common is the 
∆F508 mutation (~70% of all cases), which occurs due to a deletion of the phenylalanine 
residue at position 508 of CFTR (52;86).  Abnormalities in CFTR lead to disruption of 
anion secretion and excessive salt and water absorption in ion transport in various 
epithelial lined organs resulting in the plugging of ducts with tenacious secretions.  As a 
result, CF presents as a multi-organ disease whose manifestations include meconium 
ileus (Figure 1.4), distal intestinal obstructive disease, duodenal acidity, airway 
mucociliary clearance failure and exocrine pancreatic insufficiency (122).  A CF mouse 
 
 
A
 
Arey, J.B. and Valdes-Dapena, M., Pathology of the Gastrointestinal Tract, 1992 
 
B
 
Figure 1.4.  Photomicrograph of the small intestine (high magnification 400X) from A. a 
human CF patient with meconium ileus and B. a CF mouse.  Histopathologically, the CF 
intestine is characterized by goblet cell hyperplasia and mucoid casts within the crypts.  
The obstructive syndrome and histopathologic appearance are accurately reproduced in 
CF mouse models.  
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model was initially developed in 1992 due to targeted disruption of the murine homolog 
of the cftr gene (97).  Subsequently, additional mouse models have been generated that 
carry CFTR specific mutations corresponding to both mild (R117H) and severe (DF508, 
G551D) forms of human CF (29;115;126).  CF mouse models have been shown to lack 
cAMP-stimulated apical membrane anion secretion through CFTR in epithelial tissues 
(23); however, they do differ from human CF patients with regard to organ level 
pathology.  The mouse model accurately recapitulates the intestinal phenotype of cystic 
fibrosis exhibiting poor growth rates, duodenal acidity due to deficient HCO3- secretion, 
and a severe intestinal obstructive syndrome (97) (Figure 1.4) that can be lethal if not 
treated orally with an osmotic laxative (22).  In contrast to human CF patients, CF mice 
normally do not present with overt airway or pancreatic disease, which is proposed to be 
due to the presence of an alternate Cl- conductance pathway in these organs (23). 
 
Duodenal HCO3- Secretion 
 The alkaline mucus barrier of the duodenum plays an important role in protecting 
the epithelium from acidic chyme entering from the stomach (36).   Active HCO3- 
secretion involves the apical membrane activities of the CFTR and Cl-/HCO3- 
exchangers.  Under basal, non-stimulated conditions, pH stat studies of CF patients and 
CF mouse models indicate that bicarbonate secretion by anion exchange predominates in 
the duodenum (84).  In addition, most studies show that basal bicarbonate secretion is 
reduced in the CF duodenum, but the specific pathophysiology of the deficiency has yet 
to be elucidated (84).  In contrast to basal secretion, during cAMP stimulation (a result 
of paracrine and neural action under physiological conditions), electrogenic HCO3- 
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secretion predominates, and this response is essentially absent in the CFTR(-) 
duodenum (25;87).  Two models for cAMP-stimulated HCO3- secretion have been 
proposed as depicted in Figure 1.5 (75).  One model supports activation of an apical 
membrane HCO3- conductance.  It is known that CFTR conducts HCO3- in addition to 
Cl-, but its permeability is significantly less (PHCO3 : PCl ≈ 0.25) (41;80), and the 
permeability may be reduced further due to anomalous mole fraction behavior of the 
channel (105).  A second model proposed for cAMP-stimulated secretion involves the 
interaction of CFTR with anion exchange proteins.  Studies of pancreatic duct epithelium 
first postulated that a cAMP-stimulated Cl- channel (CFTR) indirectly facilitates Cl-
/HCO3- exchange by recycling Cl-, thus, maintaining a favorable outside:inside 
concentration gradient for Cl- (75).  Other studies of recombinant proteins indicate the 
possibility of direct intermolecular associations between anion exchange proteins and 
CFTR.  During cAMP stimulation, the STAS domain of Slc26a transporters, a major 
class of apical membrane Cl-/HCO3- exchangers, has been shown to enhance CFTR 
channel activity (56), whereas the regulatory domain of CFTR has been shown to 
increase Cl-/base exchange by these anion exchanger proteins (60). 
 Expression studies of villous epithelium show the presence of CFTR (104) and 
apical membrane Cl-/HCO3- exchanger proteins including at least two members of the 
sulfate permease family, i.e., Slc26a3 (DRA) and Slc26a6 (PAT-1), and one member of 
the anion exchanger family, Slc4a9 (AE4) (48) (Figure 1.6).  Although reduced relative 
to crypt epithelium, functional CFTR is present on the intestinal villi in both human and 
mouse (39;76).  Villi and epithelial microvilli increase the intestinal surface area by 
3Na+
2K+H+
Na+
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Na+ HCO3-
NBC
CO2
H2O
HCO3-
H+
C.A.
HCO3-
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Cl-
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Cl-
HCO3-
HCO3- Cl-
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+
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HCO3- Conductance
PHCO3-:PCl- = 1 : 4
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Na+ HCO3-
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CO2
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HCO3-
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HCO3-
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Cl-
HCO3-+
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CFTR AE
Cl-
HCO3-
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Figure 1.5.  Two proposed models for cAMP-stimulated HCO3- secretion.  One model 
(upper) supports CFTR HCO3- conductance.  The second model (lower) involves the 
interaction of CFTR with anion exchange proteins either by direct intermolecular 
association or by indirect facilitation of Cl-/HCO3- exchange.   
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Ameen et al.  Histochem . Cell. Biol . 114: 69, 2000 
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CFTR 
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Figure 1.6.  Cellular localization of CFTR, AE4, DRA, PAT-1, and PEPT1 in the 
duodenum. 
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~200-fold; thus, the contribution of HCO3- secretion from these structures is likely 
considerable.  However, little is known about the processes of HCO3- transport and their 
role in protecting these epithelial projections from the acidic luminal effluent. 
 
Apical Membrane Cl-/HCO3- Exchangers 
Anion Exchanger 4   
One member of the SLC4 bicarbonate transporter family, Slc4a9 (AE4) (125) 
has been localized to the apical membrane of duodenal villous and gastric epithelium 
(54).  Functional expression studies in Xenopus oocytes indicate that AE4 has Cl-/HCO3- 
exchange activity (125). 
Slc26a Cl-/HCO3- Exchangers   
The ten members of the multifunctional anion exchanger gene family (Slc26a) 
are responsible for transporting a wide variety of monovalent and divalent anions 
including SO42-, Cl-, I-, formate, oxalate, hydroxyl and HCO3- (72).  These transporters 
are involved in a number of physiological processes including bicarbonate secretion by 
the distal nephron and pancreas, transepithelial NaCl transport, skeletal development, 
and thyroid hormone synthesis, and mutations in at least 4 family members result in 
genetic disease (72).  Two family members, Slc26a3 (DRA) and Slc26a6 (PAT-1), have 
been conclusively shown to function as Cl-/HCO3- exchangers and are localized to the 
apical membrane of epithelial tissues, including the villous epithelium (48).  
a. DRA    
DRA was initially identified as a potential tumor suppressor that was down-
regulated in adenomas and induced growth suppression when over-expressed in 
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cultured cells (18).  DRA is predominantly expressed in the gastrointestinal tract 
with highest levels in the colon and duodenum (48).  Studies utilizing recombinant 
proteins have show that DRA transports HCO3- in exchange for luminal Cl-, SO42-, or 
oxalate (72).   Conflicting reports exist regarding the sensitivity of DRA to the 
distilbene DIDS, but niflumic acid and tenidap have been shown to be effective 
inhibitors (20;72).  Studies of recombinant DRA expressed in HEK 293 cells 
indicate that removal of extracellular Cl- causes depolarization, which has led to the 
proposal that DRA is electrogenic, exchanging > 2Cl- per HCO3- (55).  However, 
these results are at odds with studies showing that membrane depolarization with 
high external K+ concentration does not affect activity (73), and investigations of 
DRA expressed in Xenopus oocytes that have not found alterations in membrane 
potential during Cl-in/HCO3-out exchange (69;72).  Loss-of-function mutation in 
human DRA (SLC26A3) is the causal factor in the inherited disease congenital 
chloride-losing diarrhea (CLD), which results from defective intestinal Cl-/HCO3- 
exchange and is characterized by a diarrhea with high Cl- content and systemic 
alkalization (51;71).  Initial reports of clinical disease in the DRA knockout mouse 
model (i.e., diarrhea, chloride stool concentration, and growth retardation) closely 
resemble that of human CLD (17).  The severe intestinal manifestations of CLD may 
reflect a functional coupling between DRA and the major apical membrane Na+/H+ 
exchangers (NHE2 and NHE3) responsible for electroneutral NaCl absorption, as 
based on evidence of functional coupling of these exchangers in recombinant cell 
systems and changes in DRA expression in the NHE3 knockout intestine (73). 
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b.  PAT-1  
PAT-1 was first identified as the apical Cl-/formate exchanger in renal tubules, 
i.e., CFEX (53).  PAT-1 demonstrates abundant expression in the apical membrane 
of the kidney, pancreas, and intestine (53).  This exchanger is the most versatile 
member of the Slc26a family transporting Cl-, HCO3-, SO42-, oxalate, formate, and 
hydroxyl (72).  Previous transport studies indicate that PAT-1 is electrogenic but, in 
contrast to DRA, removal of extracellular Cl- results in cell hyperpolarization, 
suggesting a stoichiometry of 1Cl-:>2 HCO3- (55).  However, recent studies of 
mPAT-1 expressed in Xenopus oocytes indicate that Cl-/HCO3- exchange is 
electroneutral whereas Cl-/oxalate exchange is electrogenic (19).  Preliminary 
studies in the knockout mouse model reveal that PAT-1 is important in apical 
membrane Cl-/base exchange of the proximal renal tubule and contributes to HCO3- 
secretion in the duodenum; although investigations of PAT-1 (-) mice have revealed 
no overt disease and normal growth rates (114;119). 
 
Carbonic Anhydrase 
  Carbonic anhydrases, which efficiently catalyze the reversible hydration of CO2 
to HCO3- and H+, play a critical role in driving the transport of HCO3- across cells and 
epithelial layers.  They are categorized based upon their cellular localization: 1) cytosolic, 
2) mitochondrial, 3) membrane-associated, and 4) secreted with cytosolic CAII being the 
most widely expressed isozyme in the small intestine.  CAs are found in virtually every 
cell type and play critical roles in CO2 transport, intracellular buffering, and the 
regulation of intracellular and extracellular pH (95).  In addition, several lines of 
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evidence have demonstrated both functional and physical relationships between CAs and 
Cl-/HCO3- exchange proteins (4;102) allowing the formation of a bicarbonate transport 
metabolon that accelerates transmembrane HCO3- flux. 
 
Intestinal Transport of Peptides and Peptidomimetics   
The intestinal brush border possesses several transport systems that allow for the 
absorption of peptides and amino acids produced during luminal protein digestion.  
Evidence indicates that most amino acids are absorbed more efficiently when presented 
to the lumen in the form of small peptides, which are transported by the apical H+ peptide 
cotransporter SLC15A1 (PEPT1) (28).  The PEPT1 protein has the ability to transport all 
the 400 different dipeptides and 8000 different tripeptides derived from luminal protein 
digestion regardless of net charge, molecular size, and solubility (57).  In addition, many 
orally delivered drugs which have dipeptide and tripeptide structures, including β-lactam 
antibiotics and ACE inhibitors, and bacterial products, such as f-MLP and muramyl 
dipeptide, cross the absorption barrier by means of transport through PEPT1 
(15;38;70;116). 
PEPT1 is expressed along the longitudinal axis of the small intestine with greatest 
levels in the duodenum and jejunum.  Expression is not detectable in the crypts but 
increases from the villous base to its highest levels in the villous tips with protein 
expression almost exclusively restricted to the brush border membrane of the intestinal 
mucosa (Figure 1.6) (38).  In response to certain substrates, fasting, and starvation, 
PEPT1 expression is upregulated by means of increased PEPT1 transcription 
(74;106;117).  In addition, insulin, leptin, and clonidine may increase PEPT1-mediated 
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transport as a result of increased trafficking of PEPT1 to the apical membrane from a 
preformed cytoplasmic pool (10;14;107). 
 
Regulation of Intracellular pH (pHi) during PEPT1 Transport   
Transport via PEPT1 is electrogenic and is coupled to an inwardly directed proton 
gradient that allows for transport of peptides against a concentration gradient (65).  
H+/peptide influx exhibits a stoichiometry of 1:1, which occurs irrespective of the net 
charge associated with the peptide, but there is a clear preference for non-charged species 
(57).  Studies of intestinal cell lines have shown that proton di-/tripeptide uptake results 
in intracellular acidification, and this decrease in pHi will diminish the driving force for 
PEPT1-mediated transport unless the proton load is reduced by means of intracellular 
buffering or proton efflux (110;111).  Therefore, optimal peptide absorption must rely 
upon the cooperation of a number of transport proteins present in intestinal epithelial 
cells.  The current model for the regulation of pHi during PEPT1 transport (Figure 1.7) is 
based upon studies conducted in intestinal cell lines endogenously expressing PEPT1 and 
Na+/H+ exchanger proteins (50).  In the absence of CO2/HCO3- in the bathing medium, 
these investigations revealed that PEPT1-mediated transport activates the apical 
membrane NHE3 (112;113).  As a result, H+ can be exported across the apical membrane 
maintaining pHi and the driving force for peptide absorption.  Sodium influx via NHE3 
exits the cell by means of the basolateral Na+/K+ ATPase, and the resulting increase in 
intracellular K+ is dissipated by basolateral K+ channels.  This model, however, may be 
incomplete because it does not consider the contributions of acid-base transport proteins 
that are functional in the presence of CO2/HCO3- (i.e., under physiologic conditions).   
 3Na+
2K+
H+
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Figure 1.7.  Current model for intestinal peptide transport through PEPT1 and the 
resulting cooperative action of various membrane transport proteins based on 
recombinant protein studies and performed in the absence of CO2/HCO3- in the media. 
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One study performed in the presence of CO2/HCO3- has demonstrated  that intracellular 
carbonic anhydrase activity can facilitate diffusive H+ movement thereby maintaining a 
transmembrane ion gradient that allows for maximal absorption via PEPT1 in murine 
small intestinal villous epithelia (103).  Additional studies are required under physiologic 
conditions to gain a complete understanding of the various acid-base transport proteins 
involved in sustaining PEPT1-mediated absorption through across native epithelium.   
 
Dissertation Overview 
 This chapter gives the reader an overview of gastrointestinal ion transport 
physiology, cystic fibrosis, and peptide transport.  The following chapters summarize the 
physiology research performed by the author over the last four years.  Chapter 2 
summarizes the role of CFTR and Cl-/HCO3- exchange in the process of basal 
bicarbonate secretion in the murine duodenal villous epithelium.  In chapter 3, the 
predominant apical Cl-/HCO3- exchanger of the murine duodenal upper villus is identified 
through the use of knockout mouse models for AE4, DRA, and PAT-1.  Finally, chapter 
4 discusses a potential role for PAT-1 in the regulation of pHi during PEPT1 transport.  
Together, these chapters document an investigation of the physiologic roles of PAT-1, 
DRA, and AE4 in the murine duodenal villus and their interactions with CFTR and 
PEPT1.  Chapter 5 contains summary and conclusions from the preceding chapters and a 
discussion of potential future experiments based on this work.  
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Chapter 2 
CHLORIDE CONDUCTANCE OF CFTR FACILITATES BASAL Cl-/HCO3- 
EXCHANGE IN VILLOUS EPITHELIUM OF INTACT MURINE DUODENUM 
 
 
Introduction  
The alkaline mucus barrier of the duodenum plays an important role in protecting 
the epithelium from damage by acid chyme entering from the stomach (36).  Alkalinity of 
the surface mucus is sustained by transcellular processes of HCO3- secretion that involve 
coordination of the activities of the cystic fibrosis transmembrane conductance regulator 
(CFTR) and anion exchanger proteins (25;84;99).  Under basal, non-stimulated 
conditions, pH stat studies of cystic fibrosis (CF) patients and CF mouse models indicate 
that bicarbonate secretion by anion exchange predominates in the duodenum 
(25;26;84;87).  Most studies further show that basal HCO3- secretion is reduced in CF 
duodenum, but the pathophysiology of this deficiency has not been elucidated (26;84;87).  
In contrast to basal secretion, it is known that CFTR is essential to cAMP stimulation of 
HCO3- secretion, a consequence of increased prostanoid and neural activity induced by 
exposure of the duodenum to the gastric effluent (36).  The mechanism of this process 
has been an area of intense investigation in recent years.  Most controversy surrounds the 
question of whether CFTR, a cAMP-stimulated anion channel (6), provides a conductive 
pathway for HCO3- ions across the apical membrane of the epithelium.  CFTR is 
permeable to HCO3- but at a reduced level relative to Cl- (PHCO3 : PCl ≈ 0.25) (41;80), and 
the permeability may be reduced further due to anomalous mole fraction behavior of the 
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channel (105).  However, studies of intact intestine from animal models are consistent 
with dominance of a HCO3- conductance in that 75 - 80% of cAMP-stimulated HCO3- 
secretion is preserved in the absence of luminal (apical) Cl-, a condition that inhibits the 
activity of the apical membrane Cl-/HCO3- exchange proteins (25;99).  Interpretation of 
these data must accommodate recent evidence that CFTR permeability to HCO3- is 
dynamically regulated both by intracellular factors (85) and, important to this discussion, 
by extracellular Cl- concentration, i.e., HCO3- permeability increases in the absence of 
extracellular Cl- (89). 
A second model proposed for cAMP-stimulated secretion involves the interaction 
of CFTR with anion exchange proteins.  Studies of pancreatic duct epithelium first 
postulated that a cAMP-stimulated Cl- channel (CFTR) indirectly facilitates Cl-/HCO3- 
exchange by recycling Cl-, thus, maintaining a favorable outside:inside concentration 
gradient for Cl- (75).  Subsequent investigations of other epithelia and heterologous 
expression systems demonstrated that CFTR activation stimulates Cl-/HCO3- exchange 
activity (60;61).  In the duodenum, studies of brush border membrane vesicles have 
shown that Cl-/HCO3- exchange is increased by cAMP stimulation (33) and evidence of 
CFTR facilitation of Cl-/HCO3- exchange in intestinal mucosa was provided by 
investigations of cAMP-stimulated murine duodenum during isolation of carbonic 
anhydrase activity (25) and inhibition of the NKCC1 Na+/K+/2Cl- cotransporter (118).  
Recent studies have immunolocalized several anion exchange proteins to the apical 
membrane of intestinal epithelium including at least two members of the sulfate permease 
family, i.e., Slc26a3 (known as the down-regulated in adenoma gene DRA) and Slc26a6 
(known as the putative anion transporter-1 PAT-1 or chloride-formate exchanger CFEX), 
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and one member of the anion exchanger family, Slc4a4 (i.e., AE4) (64;79;125).  The 
Slc26a anion exchangers and CFTR possess PSD-25/Disc-large/zonula occludens-1 
(PDZ) domains that enable co-localization of these proteins on the binding sites of 
scaffolding proteins such as the Na+/H+ exchanger regulatory factor (NHERF) (59;63;91).  
Further, studies of recombinant proteins indicate the possibility of direct intermolecular 
associations between the anion exchange proteins and CFTR.  During cAMP stimulation, 
the STAS domain of Slc26a transporters has been shown to enhance CFTR channel 
activity whereas the regulatory R domain of CFTR increases Cl-/base exchange by the 
anion exchangers (56).  Thus, our model of the interactions between CFTR and the apical 
membrane anion exchangers during cAMP-stimulation must be modified to include 
molecular associations between proteins. 
Situated for direct exposure to gastric acid effluent, the villi of the duodenal 
mucosa are presented with a unique challenge in maintaining a protective alkaline mucus 
barrier.  Although it is well-documented that CFTR expression is greatest in the crypts, 
CFTR mRNA and protein expression extend to the villous tips and greatest levels of 
expression occur in the duodenum (5;104).  Evidence of CFTR channel activity in the 
villous epithelium includes X-ray microanalysis of intestinal cryosections from normal 
and CF jejuna indicating CFTR-dependent Cl- secretion (76), and BCECF studies of 
intact duodenum from normal and CF mice demonstrating the presence of a CFTR-
dependent HCO3- conductance (39).  In addition to the presence of a functional CFTR, all 
three of the known apical membrane anion exchangers (DRA, PAT-1 and AE4) in the 
duodenum have been immunolocalized to the villous epithelial cells (64;79;125).  Thus, 
the basic components for HCO3- transport are present, but little is known about the 
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physiology of HCO3- secretion across the abundant mucosal surface area of the villous 
epithelium. 
In the present study, we investigate basal activity of anion exchange across the 
apical membrane of epithelial cells in the mid-region of villi of intact duodenal mucosa 
from wild-type (WT) and CFTR-null (CF) mice using BCECF microspectrofluorimetry 
of intracellular pH (pHi).  The duodenal mucosa was mounted in a horizontal Ussing-type 
chamber that allowed independent superfusion of the luminal and basolateral surfaces of 
the epithelium.  Using this system, the characteristics of anion exchange were 
investigated in the presence or absence of CFTR activity in the villous epithelium. 
 
Materials and Methods 
Animals  
The experiments in this study used mice 8 - 12 wks old that were either 
homozygous for the S489X mutation of the murine homolog of CFTR (cftrtm1UNC) or 
homozygous for the mCFTR ∆F508 mutation (cftrtm1Kth) and maintained on a C57BL/6J 
background (>6 generations) (97;126).  The mutant mice were identified by using a PCR 
based analysis of tail snip DNA, as previously described (24).  No significant differences 
in experimental parameters were noted between the two CF mouse models which were 
compared with WT littermate mice.  All mice were maintained ad libitum on standard 
laboratory chow (Formulab 5008 Rodent Chow; Ralston Purina) and drinking water 
containing an oral osmotic laxative (Schwartz Pharma, Seymour, IN) with the following 
composition (in g/L):  60.00 polyethylene glycol 3350 (PEG), 1.46 NaCl, 0.75 KCl, 1.68 
NaHCO3, and 5.68 Na2S04.  The mice were housed singly in a temperature (22-26°C) and 
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light (12:12-h light-dark cycle)-controlled room in the Association for Assessment and 
Accreditation of Laboratory Animal Care (AAALAC) accredited animal facility at the 
Dalton Cardiovascular Research Center.  Intestinal tissues for experiments were obtained 
from mice 2-4 months of age.  The mice were fasted overnight prior to experimentation 
but were provided with water ad libitum.  All experiments involving animals were 
approved by the University of Missouri Animal and Use Committee 
Fluorescence Measurement of Intracellular pH and Image Analysis  
 The method used for imaging intact intestinal epithelium was based on techniques 
for imaging murine isolated duodenal villi, as previously described (39).  Animals were 
sacrificed by asphyxiation in a 100% CO2 atmosphere followed by bilateral 
pneumothorax.  The duodenum was removed via an abdominal incision and was 
immediately placed in an ice-cold, oxygenated Ringer’s solution.  The duodenal segment 
was opened along the mesenteric border using sharp dissection and pinned flat with 
mucosal side down in a Sylgard-filled Petri dish.  After scoring along one end of the 
preparation with a scalpel blade, the serosa and muscularis externa were removed along 
the longitudinal axis by blunt dissection using fine forceps.  Dissection was confirmed by 
histological examination.  The muscle-stripped intestinal preparations were mounted 
luminal (apical) side up on a horizontal bilateral perfusion chamber in which mucosal and 
serosal surfaces were independently bathed.  Throughout the experimental period, all 
duodenal preparations were treated with indomethacin (1 µM) and tetrodotoxin (TTX, 0.1 
µM) to minimize the effect of endogenous prostaglandins and neural tone, respectively 
(13;90).  To immobilize villi for imaging, the tips of a small percentage (< 1%) of the 
villi were trapped under strands of a loose nylon mesh that was place over the mucosal 
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surface of the preparation.  The duodenal preparation was washed with a solution 
containing 100 µM DL-dithiothreitol and then incubated with 16 µmol/L of 2’,7’-bis-(2-
carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) for 10 
minutes on the luminal side in a isethionate-bicarbonate Ringer solution (IBR) containing 
(in mM):  140.0 Na+, 55.0 Cl-, 55.0 isethionate-, 25.0 HCO3-, 5.2 K+, 5.0 N-tris methyl-2-
aminoethanesulfonic acid (TES), 4.8 gluconate-, 2.8 PO42-, 1.2 Ca2+, 1.2 Mg2+, 10.0 
glucose, and 6.8 mannitol that was gassed with 95% O2: 5% CO2 at 37°C (pH 7.4).  As 
described previously (39;44), the duodenal villous epithelium was loaded with BCECF-
AM (Figure 2.1A) and an area in the mid to upper region of a single, immobilized villus 
(~ 1 mm from the villous tip) was visualized using a 10X water-immersion objective 
(Figure 2.1B).  Approximately 10 epithelial cells were selected for ratiometric analysis 
using a 40X water immersion objective (Figure 2.1C).  Viability of the cells after 
preparation was evaluated using trypan blue exclusion.  Changes in intracellular pH (pHi) 
were measured by the dual excitation wavelength technique (440 and 495 nm) and the 
villi were imaged at a 535 nm emission wavelength.  Autofluorescence (in the absence of 
BCECF) was measured in villous epithelia from 6 mice and the average emission at each 
wavelength was subtracted for background correction.  Ratiometric images were acquired 
at 20 second intervals with a Sensi-Cam digital camera (Cooke, Auburn Heights, MI) and 
images were processed using Axon Imaging Workbench 2.2 (Axon Instruments, Union 
City, CA).  The 495: 440 nm ratios were converted to pHi using a standard curve 
generated by the K+/nigericin technique (12;108).  
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Figure 2.1.  Images of BCECF-loaded villi from murine duodenum.  A.  Low power 
image of BCECF-loaded duodenal villi visualized by conventional fluorescent 
microscopy using an upright, water-immersion objective (100X, λ 535 nm).  B.  High 
power en face image of the upper mid-region of a single, immobilized duodenal villus 
visualized by light microscopy using an upright, water-immersion objective (400X).  C.  
Enhanced high power en face image of BCECF-loaded duodenal epithelium in the mid-
region of a single villus (400 X, λ 535 nm).  White circles denote regions of interest 
within individual epithelial cells used for data acquisition. 
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Determination of Buffering Capacity and Base Flux  
 Intracellular buffering capacity (βi) of WT and CF duodenal villous cells was  
estimated by the ammonium alkalization technique (121).  Briefly, intact duodenal tissue 
was mounted in a horizontal bilateral perfusion chamber and loaded with BCECF-AM 
asdescribed above.  The tissue was superfused with a Na+ and HCO3--free ringer 
containing varying concentrations of NH4Cl.  [NH4+]i was calculated from the 
Henderson-Hasselbalch equation, and βi was determined as ∆[NH4+i]/∆pHi.  Consistent 
with previous observations (8;82), no differences in pHi between WT and CF murine 
intestinal epithelial cells were apparent.  Interestingly, the pHi of the villous epithelial 
cells in the intact mucosa (31.8 mM at pH 7.6) exceeded previous estimates of pHi in 
isolated murine colonic crypts (26.7 at pH 7.6) and isolated murine duodenocytes (6.4 
mM at pH 7.6) (8;82).  The total buffering capacity (βtotal) was calculated from the 
equation βtotal = βi + βHCO3- = βi + 2.3 x [HCO3-]i, where βHCO3- is the buffering capacity of 
the HCO3-/CO2 system and [HCO3-]i is the intracellular concentration of HCO3-.  The 
rates of pHi change measured in these experiments were converted to transmembrane net 
base flux (J(B-)) using the equation J(B-) = ∆pH/∆t x βtotal.  The βtotal values used in the 
determination of net base flux were calculated from the above equation using the average 
pHi during the 90-s period of linear ∆pH/∆t changes (see below). 
Measurement of apical membrane anion exchange   
Duodenal preparations were typically perfused with IBR on the luminal side.  The 
basolateral superfusate consisted of a Cl--Free IBR (Cl- replaced with isethionate-) gassed 
with 95% O2: 5% CO2 at 37°C (pH 7.4) and contained 1 µM 5-(N-ethyl-n-isopropyl)-
amiloride (EIPA) to block the activity of Na+/H+ exchanger isoform 1 (NHE1).  For 
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nominally HCO3--free solutions, NaHCO3 was replaced equimolar with NaTES and 
gassed with 100 % O2.  For solutions with high [K+], 75 mM NaCl and Na+-isethionate 
were replaced equimolar with KCl and K+-isethionate, respectively, in both luminal and 
basolateral superfusates.  Experiments to measure anion exchange consisted of pHi 
alkalization induced by replacement of luminal Cl- with isethionate- on an equimolar 
basis.  After a stable pHi was obtained (approximately 2 min), pHi recovery was initiated 
by replacing isethionate- with Cl-.  In some experiments, SO42- and NO3- were used to 
replace Cl- on an equimolar basis during pHi recovery.  Rates of anion exchange during 
alkalization and recovery (∆pH/∆t) were calculated from a linear regression of the values 
from the first 90 sec of the initial pHi changes during Cl- removal and replacement, 
respectively.  For inhibitor studies, 1 mM 4,4’-diisothiocyanatostilbene-2,2’-disulfonate 
(DIDS) was added to the luminal superfusate from a 10 mM stock solution in IBR or 100 
µM niflumic acid (NFA) was added to the luminal superfusate from a 100 mM stock in 
DMSO.  For glybenclamide studies, 100 µM glybenclamide was added to the luminal 
superfusate from a 250 mM stock in DMSO. 
Northern blot analysis 
Northern blot analysis of total mRNA was performed as previously described 
(21).  Total RNA from murine duodenum was extracted using TRI-Reagent (Molecular 
Research Center, Inc.), according to manufacturer’s instructions.  RNA was mixed with 
Glyoxal sample buffer (BioWhittaker Molecular Applications, Rockland, ME), 
separated by 1% agarose gel electrophoresis and transferred to a Hybond-N+ nylon 
membrane (Amersham Biosciences, Piscataway, NJ).  The blot was probed using α-
dCTP 32P-labeled cDNA PCR product for murine DRA (mDRA), murine PAT-1 
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(mPAT-1) and the L32 ribosomal protein.  For the mDRA probe, the RT-PCR product 
was obtained using the sense and antisense oligonucleotide primers with the following 
sequences:  5’-GGTTTAGCATTTGCTCTGCTGG and 5’-
TTACAGTCATGATGAGTTCGATG.  For the mPAT-1 probe, the RT-PCR product 
was obtained using the sense and antisense oligonucleotide primers with the following 
sequences:  5’-GCGACTCTCTGAAAGAGAAGTG and 5’-
TCAGAGTTTGGTGGCCAAAACA.  Radiographic density of bands was measured 
using a Kodak Imaging Station 2000R and expression levels of mDRA and mPAT-1 
were normalized to L32. 
Materials 
The fluorescent dye BCECF acetoxymethyl ester was obtained from Molecular 
Probes (Eugene, OR).  Tetrodotoxin was obtained from Biomol International L.P. 
(Plymouth Meeting, PA).  All other materials were obtained from either Sigma Aldrich 
(St. Louis, MO) or Fisher Scientific (Springfield, NJ). 
Statistics   
 All values are reported as mean ± SEM.  Data between two treatment groups were 
compared using a 2-tailed unpaired Student t-test assuming equal variances between 
groups.  Data from multiple treatment groups were compared using a one-way analysis of 
variance with a post hoc Tukey’s t-test.  A probability value of p < 0.05 was considered 
statistically significant. 
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Results 
Cl-/HCO3- exchange in villous epithelium of murine duodenum   
Cl-/HCO3- exchange function across the apical membrane of villous epithelial 
cells using BCECF microfluorimetry has not been previously demonstrated in intact 
duodenal mucosa.  The horizontal Ussing chamber system used in this study allowed 
separate superfusion of the luminal (apical) and basolateral (serosal) sides of the mucosa.  
In the basolateral superfusate, Cl- was replaced by isethionate- to minimize the 
contribution of basolateral anion exchange activity and 1 µM EIPA was included in the 
solution to inhibit basolateral Na+/H+ exchanger isoform 1 (NHE1).  A standard 
experimental paradigm (see Figure 2.2A) to demonstrate Cl-/base exchange activity 
involves the replacement of luminal superfusate Cl- with the impermeant ion isethionate-, 
resulting in rapid alkalization of the pHi as the exchange process runs in reverse mode 
(Cl-out/HCO3-in).  Return of luminal superfusate Cl- rapidly acidifies (i.e., recovers) pHi to 
baseline values as the exchanger process runs in forward mode (Cl-in/HCO3-out).  To 
investigate the Cl- dependence of the anion exchange process, Cl- was not returned to the 
luminal superfusate after maximal alkalization by Cl- removal.  As shown in Figure 2.2B, 
the pHi acidified very little for the duration of the experiment (> 10 min).  To determine 
whether the anion exchange process was dependent on HCO3-, CO2/HCO3- was removed 
from the superfusates and the duodenum was treated with 100 µM methazolamide to 
inhibit endogenous carbonic anhydrase activity during the Cl- substitution protocol.  As 
shown in Figure 2.2C, Cl--dependent alkalization and recovery was greatly diminished 
during removal of CO2/HCO3- from the superfusing solutions.  Addition of CO2/HCO3- to 
the superfusates re-established anion exchange activity.  Thus, the process of  
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Figure 2.2.  Anion exchange in duodenal villous epithelium exhibits Cl- and HCO3- 
dependence.  A.  Standard experimental paradigm demonstrating pHi change as a result 
of Cl-/base exchange activity in duodenal villous epithelial cells during changes in 
extracellular Cl- concentration (Cl-o).  B.  Representative pHi trace of duodenal villous 
epithelial cells during luminal Cl- removal (replacement with isethionate).  Following 
alkalization, pHi remains constant for the duration of the experiment (>10 min) 
demonstrating a dependence on Cl-o for recovery from alkalization.  Trace representative 
of n = 3 experiments.  C.  Representative pHi trace of duodenal villous epithelial cells 
during luminal Cl- removal and replacement in the presence and absence of HCO3-/CO2.  
In the absence of HCO3-/CO2, villous epithelial cells exhibit minimal Cl-/base activity 
(~20% of the activity in the presence of HCO3-/CO2).  Trace representative of n = 3 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 
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Cl--dependent alkalization and recovery in the duodenal villus epithelium is primarily 
dependent on the presence of HCO3-, indicating dominance of Cl-/HCO3- rather than Cl-
/OH- exchange. 
Reduced Cl-/HCO3- exchange activity in the villous epithelium of CF mouse duodenum   
 Under basal conditions, both WT and CF intestine exhibit a finite rate of 
transepithelial HCO3- secretion that involves the activity of an apical membrane Cl-/base 
exchange process (25;26;84;87).  Several studies show that the rate of HCO3- secretion 
across CF duodenum is reduced relative to the WT intestine (26;84;87).  Therefore, we 
compared the rates of Cl-/HCO3- exchange activity in the villous epithelium between CF 
and WT murine duodena.  As shown by the experiment in Figure 2.3A, the basal pHi of 
the villous epithelium is elevated and the rates of alkalization and recovery during Cl- 
substitution/replacement are reduced in CF as compared to WT duodenum.  Cumulative 
data for several experiments on CF and WT epithelia show that the baseline pHi (Figure 
2.3B) is significantly more alkaline in the CF villi and both the rates of HCO3- influx 
during Cl- removal and HCO3- efflux during Cl- replacement are reduced relative to the 
WT villi (37% and 30%, respectively; Figures 2.3C and 2.3D).  No differences in Cl-
/HCO3- exchange activity were found between duodenal epithelium from the CFTR 
knockout (cftrtm1UNC) and ∆F508 mCFTR (cftrtm1Kth) mice, although it was anticipated 
that differences in the latter mouse model might exist due to the potential for exchanger 
interaction with expressed mCFTR mutant protein (55).  However, unlike some ∆F508 
mCFTR mouse models (37), mRNA expression of the ∆F508 mCFTR is severely 
reduced (75 – 80%) in cftrtm1Kth mice resulting in intestinal transport properties that more 
closely resemble the mCFTR knockout intestine (126). 
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Figure 2.3.  Comparison of pHi and Cl-/HCO3- exchange in duodenal villous epithelium 
of WT and CF mice.  A.  Representative pHi trace of WT and CF duodenal villous 
epithelial cells during luminal Cl- removal and replacement.  B.  Summary of baseline 
pHi in duodenal villous epithelial cells of WT and CF mice (n = 11).  The cumulative 
data show a significantly elevated baseline pHi in CF compared to WT.  C and D.  
Summary of HCO3- influx (C) and HCO3- efflux rates (D) in duodenal villous epithelial 
cells from WT (n=9) and CF (n=8) mice.  The cumulative data show reduced rates of Cl-
/HCO3- exchange following luminal Cl- removal and replacement in CF compared to WT.  
*Significantly different from WT.
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Properties of apical membrane Cl-/HCO3- exchange are similar in WT and CF villous 
epithelia   
 To examine whether the characteristics of the Cl-/HCO3- exchange are similar 
between CF and WT villi, we compared inhibitor sensitivity, transport electrogenicity 
and anion selectivity of the villous anion exchange process.  In inhibitor studies, the 
effects of two inhibitors of anion exchange, the distilbene DIDS and NFA (8), on Cl-
/HCO3- exchange rate were examined in CF and WT villi (Figure 2.4).  DIDS, at a 
concentration (1 mM) known to inhibit activity of recombinant isoforms of both the 
Slc26a and Slc4 transport families, had very little effect on the rates of villous epithelial 
anion exchange when applied to the luminal superfusate in either WT or CF duodenum (< 
5 %).  In contrast, NFA significantly inhibited the rate of Cl-/HCO3- exchange to a similar 
degree (60 %) in both WT and CF intestine. 
 Recent studies have indicated that members of the Slc26a family of anion 
exchangers, i.e., DRA and PAT-1, possess electrogenic properties when examined in 
recombinant systems (55;72;124).  To investigate electrogenic properties of the villous 
Cl-/HCO3- exchange process, the K+ concentration in both the luminal and basolateral 
superfusate was increased to 80 mM to depolarize the membrane potential of the villous 
epithelial cells.  As shown in Figure 2.5, cell depolarization significantly increased the 
mean rate of HCO3- influx during Cl- removal in both the WT and CF villous epithelium, 
whereas the mean rate of HCO3- efflux during Cl- replacement was not significantly 
different in the high [K+] medium.  Thus, the qualitative effect of membrane 
depolarization on Cl-/HCO3- exchange is similar between WT and CF duodenal villi.  In 
the case of the CF intestine, where the CFTR conductive pathway in the apical membrane
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Figure 2.4.  Effect of anion exchange inhibitors on Cl-/HCO3- exchange rates in WT and 
CF villous epithelium.  Intact duodenum was superfused in the luminal bath for 5 minutes 
with 1 mM DIDS or 100 µM NFA prior to luminal Cl- removal and replacement.  In the 
presence of 1 mM DIDS, the rate of HCO3- efflux was minimally inhibited in both WT 
and CF duodena (n = 4).  In the presence of 100 µM NFA, HCO3- efflux was reduced by 
~60% in both WT (n=5) and CF (n=4) duodena.  
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Figure 2.5. Effect of cell depolarization on Cl-/HCO3- exchange rates in A.  WT and      
B.  CF villous epithelia.  Intact duodenum was superfused bilaterally with medium 
containing 80 mM K+ during luminal Cl- removal and replacement.  In the presence of 
the high [K+], the rate of HCO3- influx during luminal Cl- removal was significantly 
increased, whereas the rate of  HCO3- efflux during Cl- replacement was unaffected in 
WT (n=8) or CF (n=7) duodenal villous epithelia.  *Significantly different from WT 
(n=9) or CF (n=8) controls (i.e., normal IBR medium). 
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is not present, the stimulatory effect of depolarization on HCO3- influx suggests the 
dominance of an anion exchanger that hyperpolarizes the apical membrane upon Cl- 
removal. 
Investigation of reduced Cl-/HCO3- exchange in the CF villous epithelium   
 The anion selectivity of CFTR has been well-characterized (62) and it is known 
that members of the Slc26a anion exchangers transport a number of monovalent and 
divalent anions (72).  Therefore, we investigated the ability of selected anions to support 
CFTR-facilitated anion exchange.  CFTR is essentially impermeant to SO42- (47), 
whereas recombinant Slc26a anion exchangers, including DRA and PAT-1 (72), are 
capable of transporting SO42- (although the rate of SO42- transport by DRA may be very 
low (20).  To compare SO42- transport between WT and CF villous epithelium, we 
measured the rates of SO42--dependent HCO3- efflux (SO42-in/HCO3-out) following pHi 
alkalization induced by luminal Cl- removal.  As shown in Figure 2.6A (left panel), the 
SO42--dependent HCO3- efflux in WT villous epithelium occurred at a significantly 
reduced rate as compared to recovery induced by luminal Cl- addition.  In contrast, the 
SO42--dependent HCO3- efflux after alkalization was not different from the rate of Cl--
dependent HCO3- efflux in the CF villous epithelium (Figure 2.6A, right panel).  Note 
also that the mean rates of SO42--dependent HCO3- efflux were nearly identical between 
WT and CF villous epithelium.  Since SO42- does not permeate CFTR (47), these findings 
suggest that CFTR facilitates Cl-/HCO3- exchange in the WT duodenal villous epithelial 
cells by providing a “leak” pathway for intracellular Cl-, whereas this pathway is not 
available for SO42- and thus the rates of SO42-/HCO3- exchange are similar to CF 
epithelial cells.  As a test of this hypothesis, we measured the rate of NO3--dependent 
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Figure 2.6.  Effects of anion substitution or glybenclamide on HCO3- efflux in WT and 
CF duodenal villous epithelia.  A.  Comparison of HCO3- efflux rates during luminal 
superfusion with 55 mM Cl-, SO42- or NO3- following pHi alkalization induced by luminal 
Cl- removal.  In WT duodenal epithelium (left panel), HCO3- efflux rate was increased 
over CF duodenal epithelium only in the presence of luminal Cl- or NO3-, but not SO42-  
(n = 9).  In CF duodena (right panel), similar rates of HCO3- efflux were measured with 
55 mM Cl-, SO42- or  NO3-  (n = 5 - 8).  a,b,cMeans with the same letters are not 
statistically different within either the WT or CF group.  *Significantly different from 
WT.  B.  Intact duodenum was treated for 5 minutes with 100 µM glybenclamide 
(luminal superfusate) prior to luminal Cl- removal and replacement.  HCO3- efflux was 
significantly reduced in WT but unaffected in CF villous epithelium (n = 8 WT and 4 
CF).  Control WT and CF duodena were treated with 0.4 % DMSO vehicle (n = 8 WT 
and 3 CF).  *Significantly different from control. 
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HCO3- efflux following epithelial alkalization.  CFTR also conducts NO3- ions (GCl : 
GNO3 = 0.8, (47) and, like SO42-, NO3- can support anion exchange by DRA and PAT-1 
(32;124).  As shown in Figure 2.6A, the rate of NO3--dependent HCO3- efflux was 
significantly increased relative to SO42--dependent HCO3- efflux in WT villous 
epithelium.  However, in CF epithelium, the rate of NO3--dependent HCO3- efflux was 
equivalent to that measured for Cl- and SO42-.  These data are consistent with CFTR 
facilitation of anion exchange by providing a NO3- leak pathway.  Next, as a further test 
of the hypothesis, we measured the rates of Cl--dependent pHi alkalization and recovery 
during treatment of the intestine with the CFTR-selective channel blocker, glybenclamide 
(30).  Preliminary studies using murine duodenum mounted in Ussing chambers indicated 
that 1 mM glybenclamide in the luminal bath inhibited the forskolin-induced short-circuit 
current by 78 % (Vehicle ∆Isc = 187.8 ± 44.1; Glybenclamide ∆Isc = 41.2 ± 8.6 µA/cm², 
n = 4, p < 0.05).  As shown in Figure 2.6B, the rate of Cl-/HCO3- exchange in WT villous 
epithelium pretreated with glybenclamide was significantly reduced relative to the 
vehicle (DMSO)-treated epithelium, whereas no change in the rates of Cl-/HCO3- 
exchange were apparent in the CF villous epithelium. 
 The above studies are consistent with the hypothesis that the CFTR facilitation of 
apical membrane Cl-/HCO3- exchange requires the anion conductive properties of CFTR.  
However, an alternative hypothesis is that both SO42- and glybenclamide reduce the rate 
of HCO3- efflux by blocking a HCO3- current mediated by CFTR.  While this alternative 
hypothesis may be consistent with the action of glybenclamide, previous studies using 
extracellular SO42- have not demonstrated blockade of the CFTR channel pore  
 40
(35;77).  Since it is possible that intracellular SO42- may block the CFTR channel, we 
investigated whether the rate of Cl--dependent HCO3- efflux was reduced in WT 
epithelium following a period of SO42- uptake resulting from SO42-in/HCO3-out exchange.  
As shown in Figure 2.7, initial exposure of the epithelium to SO42- induced a finite rate of 
HCO3- efflux but replacement of SO42- with Cl- rapidly increased the rate to levels typical 
of Cl--dependent HCO3- efflux.  Since SO42- uptake did not alter the subsequent rate of 
Cl-/HCO3- exchange in WT epithelium, this finding suggests that intracellular SO42- 
accumulation in the villous epithelium does not affect the anion conductive properties of 
CFTR. 
 The anion substitution studies indicated the presence of apical membrane anion 
exchanger(s) that can readily perform SO42-in/HCO3-out exchange.  If recent studies 
indicating very limited SO42- transport by hDRA (20) are also true for murine DRA 
(mDRA), it is possible that a drastic reduction in mDRA expression in the CF mouse 
intestine could explain the reduced rates of Cl-/HCO3- exchange.  In other words, if both 
mDRA and mPAT-1 contribute to Cl-/HCO3- exchange but only mPAT-1 contributes to 
SO42-/HCO3- exchange, then loss of mDRA expression in the CF intestine would result in 
reduced Cl-/HCO3- exchange and unchanged SO42-/HCO3- exchange relative to WT 
intestine.  This possibility is strengthened by studies of recombinant proteins that show a 
positive correlation between the expression of CFTR and the anion exchangers, DRA and 
PAT-1 (42).  Therefore, we investigated the mRNA expression of DRA and PAT-1 in the 
WT and CF proximal intestine.  As shown in Figure 2.8, Northern blot analysis indicated 
only a slight, non-significant decrease in DRA (~25%) and essentially no change in PAT-
1 mRNA expression in the CF as compared to the WT duodenum.  Although measures 
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Figure 2.7.  Effect of a preceding period of SO42- uptake on Cl-/HCO3- exchange in WT 
duodenal villous epithelium.  Left panel, representative pHi trace of WT duodenal villous 
epithelial cells.  Following alkalization secondary to luminal Cl- removal, 55 mM SO42- 
was introduced in the luminal superfusate to allow SO42- uptake by SO42- in/HCO3-out 
exchange.  This period was immediately followed by equimolar replacement of luminal 
SO42- with Cl-, resulting in a typical rate of Cl-/HCO3- exchange (HCO3- efflux).  Right 
panel, summary of HCO3- efflux rates (mean ± SE) induced by luminal SO42- followed 
by luminal Cl- in duodenal villous epithelial cells (n = 6 mice), indicating that a preceding 
period of SO42- uptake by the epithelium does not decrease the rate of Cl--dependent 
HCO3- efflux.  *Significantly different from SO42-. 
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Figure 2.8.  mRNA expression of Slc26a3 (mDRA) and Slc26a6 (mPAT-1) in the small 
intestine of gender-matched littermate WT and CF mouse pairs.  A.  Representative 
Northern blot of mDRA, mPAT-1, and L32 ribosomal protein (as a loading control) in 
the small intestine of 3 pairs of gender-matched WT and CF littermate mice.  B.  
Densitometric analysis of mRNA expression for mDRA and mPAT-1 normalized to the 
mRNA expression of L32 ribosomal protein (n = 3 mouse pairs). 
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of protein expression or functional studies in knockout mice will be necessary to confirm 
these findings, the present data do not indicate a major reduction in the expression of 
DRA in the CF duodenum. 
 
Discussion 
 In the present study, in situ measurements of epithelial cells from the mid-region 
of duodenal villi demonstrated robust activity of Cl-/HCO3- exchange across the apical 
membrane.  Dependence of anion exchange activity on luminal Cl- was shown by 
sustained intracellular alkalization during substitution of Cl- with the impermeant anion, 
isethionate-.  The process was also found to be primarily HCO3--dependent in studies 
where CO2/HCO3- was removed from the luminal and basolateral bathing media.  The 
rates of alkalization and recovery in the absence of CO2/HCO3-, i.e., Cl-/OH- exchange, 
were less than 15 % and 24 %, respectively, of the rates in the presence of CO2/HCO3-.  
An important observation was the finding that the Cl-/HCO3- exchange activity in CF 
duodenal villous epithelial cells was reduced by approximately one-third relative to WT 
cells.  Despite reduced activity, investigations of inhibitor sensitivity and responses 
during membrane depolarization did not reveal overt differences in the characteristics of 
the anion exchange process between WT and CF duodenum. 
In the inhibitor studies, treatment with the distilbene DIDS reduced Cl-/HCO3- 
exchange by less than 5 % in both WT and CF villous epithelium.  DIDS resistance is 
consistent with properties reported for recombinant mDRA (69) but not for recombinant 
mPAT-1 or rat AE4 proteins (49;54;124).  In contrast to the effect of DIDS, NFA 
treatment substantially reduced villous Cl-/HCO3- activity by an equivalent degree in both 
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WT and CF duodenum.  Studies of recombinant hDRA, hPAT-1 and mPAT-1 have 
demonstrated that these proteins are sensitive to NFA ((20), Chernova MN, Alper SL, et 
al, manuscript submitted); however, we are unaware of similar studies performed on the 
mDRA ortholog.  Membrane depolarization using high [K+] media also produced similar 
effects on the Cl-/HCO3- exchange process in WT and CF duodena.  In both cases, 
depolarization enhanced the rate of HCO3- influx during luminal Cl- removal.  Recent 
studies of recombinant mDRA and hPAT-1, but not rat AE4, indicate the transport 
activity of these proteins exhibit electrogenic properties (49;54;55;124).  In the case of 
hPAT-1, removal of extracellular Cl- induces membrane hyperpolarization and has led to 
the proposal that the apparent stoichiometry of the protein is 1 Cl-/ ≥ 2 HCO3- (55)  In 
contrast, removal of extracellular Cl- from cells expressing recombinant mDRA caused 
membrane depolarization, suggesting an apparent stoichiometry of ≥ 2 Cl-/ 1 HCO3-.  It 
has been further proposed that equal expression of these two exchangers would result in 
electroneutral activity because of their opposing effects on membrane potential (55).  
However, this hypothesis was not supported in our studies of villous epithelium because 
membrane depolarization significantly increased the rate of HCO3- influx during luminal 
Cl- substitution. 
 Previous studies of cAMP regulation of HCO3- secretion in pancreatic ducts led to 
the proposal that the presence of a chloride channel in the apical membrane facilitates Cl-
/HCO3- exchange by recycling or leaking Cl- back to the extracellular milieu, thereby 
providing a favorable Cl- concentration gradient for exchange activity.  Several lines of 
evidence suggest that this model also explains the present observation that Cl-/HCO3- 
exchange activity is greater in WT versus CF villous epithelium under basal conditions.  
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First, only anions that permeate CFTR, i.e., Cl- and NO3- but not SO42-, produced greater 
rates of anion exchange in WT villous epithelium.  In contrast, the rate of SO42-/HCO3- 
exchange in the WT cells was equivalent to that in the CF epithelium.  Because neither 
SO42- nor NO3- reduced the rate of anion exchange in the CF duodenum, the results 
indicate that these anions fully support the activity of the anion exchanger(s).  Secondly, 
the lower rate of SO42--dependent HCO3- efflux in the WT epithelium did not result from 
SO42- blockade of a CFTR-mediated HCO3- conductance because the rate of Cl--
dependent HCO3- efflux was not reduced by preceding the experiment with a period of 
SO42- uptake across the apical membrane.  Third, treatment of the WT epithelium with 
the CFTR-selective channel blocker glybenclamide also reduced the rate of Cl-/HCO3- 
exchange to a level equivalent with that in CF epithelium.  Since the rate of Cl-/HCO3- 
exchange was not reduced in the CF epithelium treated with glybenclamide, it is unlikely 
that the effect of the channel blocker in the WT epithelium was due to non-specific 
effects of the compound.  The above data support the conclusion that the Cl- channel 
function of CFTR facilitates the activity of Cl-/HCO3- exchange in the villous epithelium 
of the murine duodenum under basal conditions.  However, it should be emphasized that 
this conclusion only applies to the basal, unstimulated condition and, specifically, to Cl-
in/HCO3-out exchange, a physiologically-relevant transport mode in duodenal villous 
epithelium. 
Although the transport studies support the hypothesis that CFTR Cl- conduction 
supports Cl-/HCO3- exchange in duodenal villi, the possibility was raised that reduced Cl-
/HCO3- exchange in the CF epithelium may result from decreased expression of an anion 
exchanger that does not transport SO42-, e.g., DRA (20).  However, the mRNA expression 
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of mDRA was not significantly reduced in the CF duodenum.  These data are consistent 
with previous studies which found only slight or no decrease in DRA mRNA expression 
in the distal intestine of CFTR-null mice (20), but contrary to the effect of recombinant 
CFTR expression on native DRA and PAT-1 expression in pancreatic duct cell lines (42).  
Although large changes in DRA expression sufficient to account for the differences in Cl-
/HCO3- exchange activity in the CF duodenum were not apparent from the Northern blot 
analysis, additional studies measuring surface protein levels will be necessary to fully 
evaluate the contribution of changes in DRA expression to the reduced rates of Cl-/HCO3- 
exchange in the CF duodenum. 
It was interesting that basal pHi in the CF duodenal epithelium was significantly 
more alkaline than WT under the conditions of our study.  Previous reports of CF 
pancreatic duct epithelial cell lines have found pHi to be alkaline relative to CFTR-
corrected cells, whereas no pHi difference was apparent in primary CF airway epithelial 
cells (34;123).  Important to the present discussion, no differences from WT were found 
in measurements of pHi of isolated enterocytes from both human and murine CF duodena 
(82;84), nor in in vivo preparations of intact duodenum from CFTR-deficient mice (44).  
However, in the latter study, exposure of the murine duodenum to luminal acid revealed 
differences in the CO2/HCO3--dependent buffering power in the CF epithelium that was 
tentatively ascribed to the imbalance resulting from intact HCO3--loading processes and 
the absence of CFTR-mediated HCO3--unloading mechanism.  Likewise, in the present 
study, the condition of disabling basolateral “house-keeping” pHi regulation by NHE1 
(EIPA treatment) and AE2 (basolateral Cl- removal) potentially accentuated CO2/HCO3--
dependent buffering power in the CF duodenal epithelium.  HCO3--loading processes of 
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NaHCO3 cotransport and intracellular carbonic anhydrase activity were left intact.  Thus, 
an imbalance resulting in increased pHi may have been created in the CF villous 
epithelium which lacked CFTR facilitation of basal Cl-/HCO3- exchange activity. 
Our studies indicate that the Cl- channel activity of CFTR is necessary for 
increased rates of Cl-in/HCO3-out exchange in WT epithelium under basal conditions.  The 
efficiency of this interaction may require a close association between the Cl-/HCO3- 
exchanger(s) and CFTR either by direct binding or through scaffolding protein co-
localization (55;56;59;63).  Interestingly, Figure 2.5 shows that even under membrane 
depolarizing conditions (high [K+]), that the rate of HCO3- influx during luminal Cl- 
removal remains greater in WT than CF epithelium (WT = 23.6 ± 0.9 vs. CF = 16.5 ± 2.0 
mM/min, p < 0.05).  These data suggest that CFTR also facilitates Cl-out/HCO3-in 
exchange, a process not predicted to require a Cl- leak pathway.  Although the 
observation may be indirect evidence of a functional intermolecular interaction between 
the Cl-/HCO3- exchanger(s) and CFTR, other explanations for increased alkalization in 
WT epithelium during luminal Cl- removal can be offered including additive effects of 
luminal Cl- removal and high [K+] medium on membrane depolarization and increased 
HCO3- influx via CFTR in the nominal absence of luminal Cl- (89).  Nonetheless, given 
earlier estimates of luminal ionic content (81), it seems unlikely that the luminal Cl- 
concentration in the duodenum would decrease to levels sufficiently low for sustained Cl-
out/HCO3-in exchange activity in vivo. 
 The present data are sufficient to allow a tentative conclusion regarding the 
identity of the predominant apical membrane Cl-/HCO3- exchanger in the duodenal 
villous epithelium.  A major difficulty with this exercise is that the characteristics of the 
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anion exchangers are almost exclusively based on studies of recombinant proteins 
expressed in heterologous cell systems.  Although necessary to isolate the protein’s 
activity, the knowledge derived from those investigations are limited by factors such as 
expression level, lack of native binding partners, experiments performed at non-
physiological temperatures and the use of a single splice variant of the proteins.  Given 
these limitations, some comparisons of recombinant protein studies can be drawn with 
characteristics of Cl-/HCO3- exchange activity in the villous epithelium.  The inhibitor 
studies indicated a transport process insensitive to DIDS but significantly inhibited by 
NFA.  Although this characteristic is consistent with a report on recombinant murine 
DRA which showed less than 25% inhibition by DIDS (69), additional studies on this and 
other murine orthologs of anion exchangers may be necessary because the effect of DIDS 
on the human DRA has remained controversial despite five studies reporting experiments 
(16;20;69;71;92).  Another identifying characteristic was shown by studies inducing 
membrane depolarization with high [K+] medium which increased the rate of HCO3- 
influx during luminal Cl- removal.  Membrane depolarization would favor the activity of 
murine PAT-1, which has been shown to hyperpolarize the cell during Cl- removal (72).  
Since the rate of HCO3- influx was also increased by membrane depolarization in CF 
epithelium, the aforementioned switching effect of luminal Cl- removal on CFTR 
permeability to HCO3- would not be a consideration.  Finally, the high rate of SO42-
/HCO3- exchange in the villous epithelium is also consistent with the activity of murine 
PAT-1.  Studies of murine PAT-1 have shown robust SO42- transport (72).  In contrast, 
although DRA has been reported as a sulfate transporter (92), 35SO42- uptake studies of 
human and murine recombinant DRA show transport rates that are at least 3 orders of 
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magnitude less than the SO42-/HCO3- exchange rates measured in the present study, 
which would be too low to appreciably alter pHi ((20); J. Simpson, unpublished 
observations).  Thus, based on the effects of membrane depolarization and high rates of 
SO42- transport, the data suggests that mPAT-1 provides a major portion of the anion 
exchange activity in the villous epithelium of the murine duodenum.  Thus, based on the 
effects of membrane depolarization and high rates of SO42- transport, the data suggests 
that mPAT-1 provides a major portion of the anion exchange activity in the villous 
epithelium of the murine duodenum.  However, it should be emphasized that this 
conclusion only applies to the villous epithelium located in the upper one-half of murine 
duodenal villi.  The contribution of villous PAT-1 Cl-/HCO3- exchange to the absolute 
rates of transepithelial HCO3- secretion and Cl- absorption across murine duodenum is yet 
unknown.  Previous studies have indicated that DRA Cl-/HCO3- exchange provides a 
major contribution to electroneutral HCO3- secretion in the duodenum of several species 
(48).  Other members of the Slc26a family of anion transporters and AE4 also likely 
contribute to transepithelial anion transport.  Thus, the activity of these anion exchange 
proteins in the lower villous and crypt epithelia, where CFTR expression is greatest, may 
have a dominant role in transepithelial HCO3- secretion and Cl- absorption in the 
duodenum.  Additional studies of recombinant proteins and Slc26a anion exchanger 
knockout mice will be necessary to evaluate these hypotheses. 
 The results of the present study suggest that CFTR facilitates anion exchange 
activity in the villous epithelium by providing a Cl- ‘leak’ channel that enables sustained 
Cl-in/HCO3-out exchange activity under basal (non-stimulated) conditions.  
Physiologically, this mechanism may be important in restoring the alkaline mucus barrier 
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during interdigestive periods.  The HCO3- secretory mechanism is compromised in the 
CF duodenum but the adverse effects of this deficiency may be compensated by 
increased CO2/HCO3--dependent intracellular buffering power which protects the 
epithelial cell from acid insult (44).  In WT epithelium, the efficiency of Cl- recycling for 
anion exchange is likely increased by co-localization of CFTR with the anion 
exchanger(s) at the apical membrane.  However, it was unnecessary in these studies to 
postulate a direct regulatory interaction between CFTR and the anion exchangers to 
explain the passive role of CFTR in facilitating Cl-in/HCO3-out exchange.  Although CFTR 
may have a different, perhaps direct, regulatory relationship during the Cl-out/HCO3-in 
transport mode, the reduced expression of CFTR in the villous epithelium (104) makes it 
difficult to envision a one-to-one molecular interaction with the anion exchanger(s).  
Based on the relative equality of macroscopic flux rates (24;40), it would be anticipated 
that the number of CFTR channels which transport ~1 x 106 ions/sec may be 1 - 2 orders 
of magnitude less than the number of anion exchangers which transport at 1 - 5 x 104 
ions/sec (1).  Thus, the current model for interactions between CFTR and the Slc26a 
anion exchangers may require modification for epithelia where low-levels of CFTR 
expression provide indirect regulation of Cl-/HCO3- exchange activity. 
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Chapter 3 
PAT-1 IS THE PREDOMINANT APICAL MEMBRANE Cl-/HCO3- EXCHANGER 
IN THE UPPER VILLOUS EPITHELIUM OF MURINE DUODENUM 
 
 
Introduction 
Duodenal epithelial bicarbonate secretion plays a critical role in the protection of 
the epithelium against damage from acidic chyme entering into the proximal duodenum 
(36).  The process of active HCO3- secretion across the duodenum involves the apical 
membrane activities of the cystic fibrosis (CF) transmembrane conductance regulator 
(CFTR) and anion exchanger protein(s), which mediate Cl- absorption in exchange for 
luminal HCO3- secretion (25;84;99).  Under basal (unstimulated) conditions, studies in 
several species indicate that Cl-/HCO3- exchange dominates duodenal HCO3- secretion 
and, in the CFTR(-) intestine, affords a degree of protection against acidic luminal pH 
(25;26;83;99).  However, the identity of the anion exchange protein(s) involved in 
duodenal bicarbonate secretion and their functional contribution along the crypt-villus 
axis has yet to be resolved. 
The principal candidates for this process are two members of the multifunctional 
anion exchanger (Slc26a) family, i.e., Slc26a3 [known as downregulated in adenoma 
(DRA)] and Slc26a6 [known as the putative anion exchanger (PAT-1) or chloride 
formate exchanger], and one member of the bicarbonate transporter family (Slc4a), i.e., 
Slc4a9 (known as anion exchanger isoform 4 (AE4)].  All three anion exchangers have 
been immunolocalized to the apical membrane of the intestinal epithelium, especially 
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along the villous axis (48;54;120;125).  Studies utilizing recombinant proteins have show 
that DRA transports HCO3- in exchange for luminal Cl-, SO42-, or oxalate (72).  PAT-1 is 
more versatile, demonstrating Cl-, oxalate, SO42-, formate, HCO3-, and hydroxyl transport 
in Xenopus oocytes (72).  Less well characterized is AE4, but functional expression 
studies show AE4 exhibits Cl-/HCO3- exchange (125). 
Disease causing loss-of-function mutations have not been reported for human 
PAT-1 (SLC26A6) or AE4 (SLC4A9).  However, loss-of-function mutations in DRA 
(SLC26A3) are the causal factor in the inherited disease congenital chloride-losing 
diarrhea (CLD).  These patients have defective intestinal Cl-/HCO3- exchange and the 
symptoms of diarrhea with high Cl- content and systemic alkalization (51;71).  Likewise, 
initial reports of clinical disease in the DRA knockout mouse model (i.e., diarrhea, 
chloride stool concentration, and growth retardation) closely resemble that of human 
CLD (17).  The severe intestinal manifestations of CLD may reflect interaction between 
DRA and the major apical membrane Na+/H+ exchangers (NHE2 and NHE3) responsible 
for electroneutral NaCl absorption, as based on evidence of functional coupling of these 
exchangers in recombinant cell systems and changes in DRA expression in the NHE3 
knockout intestine (69;73). 
Duodenal villi are directly exposed to gastric acid chyme emptying from the 
stomach, but little is known regarding the physiology of bicarbonate transport in the 
villous epithelium where DRA, PAT-1, and AE4 are reportedly expressed.  Therefore, in 
the present study, we specifically evaluate the basal activity of anion exchange across the 
apical membrane of epithelial cells in the upper half of villi in intact duodenal mucosa.  
Using mice with gene-targeted deletions of PAT-1, DRA, and AE4 and their wild-type 
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(WT) littermates, rates of anion exchange are measured by BCECF-AM microfluorimetry 
of intracellular pH (pHi) to assess the relative contributions of each exchanger to the 
process of apical Cl-/HCO3- exchange across the duodenal upper villous epithelium. 
 
Material and Methods 
Animals   
 The experiments in this study were performed on mice with the gene-targeted 
disruptions of the murine homologs of PAT-1 (119), DRA (17), and AE4.  All 
comparisons were made with gender- and age-matched (+/+) siblings (WT).  The mutant 
mice were identified by using a PCR based analysis of tail snip DNA, as previously 
described (24).  All mice were maintained ad libitum on standard laboratory chow 
(Formulab 5008 Rodent Chow; Ralston Purina) and tap water.  The mice were housed 
singly in a temperature (22-26°C) and light (12:12-h light-dark cycle)-controlled room in 
the AAALAC accredited animal facility at the Dalton Cardiovascular Research Center.  
Intestinal tissues for experiments were obtained from mice 2-4 months of age.  These 
mice were fasted overnight prior to experimentation but were provided with water ad 
libitum.  All experiments involving animals were approved by the University of Missouri 
Animal Care and Use Committee. 
Fluorescence Measurement of Intracellular pH and Image Analysis  
 The method used for imaging villous epithelial cells in intact murine intestine has 
been previously described (39;93).  Briefly, after euthanasia of the mouse, the proximal 
duodenum was isolated, stripped of the outer muscle layers by blunt dissection and 
mounted luminal side up in a horizontal Ussing-type perfusion chamber where luminal 
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and serosal surfaces of the tissue were independently bathed.  The luminal superfusate 
was an isethionate-bicarbonate Ringer solution (IBR) containing (in mmol/L): 140.0 Na+, 
55.0 Cl-, 55.0 isethionate-, 25.0 HCO3-, 5.2 K+, 5.0 N-tris methyl-2-aminoethanesulfonic 
acid (TES), 4.8 gluconate-, 2.8 PO42-, 1.2 Ca2+, 1.2 Mg2+, 10.0 glucose, and 6.8 mannitol 
that was gassed with 95% O2: 5% CO2 at 37°C (pH 7.4).  The serosal superfusate was a 
Cl--Free IBR (Cl- replaced with isethionate) gassed with 95% O2: 5% CO2 at 37°C (pH 
7.4).  All duodena were treated with indomethacin (1 µM), bilateral and tetrodotoxin 
(TTX, 0.1 µM), serosal to minimize the effect of endogenous prostaglandins and neural 
tone, respectively (13;90).  During superfusion, the duodenum was treated on the serosal 
side with 1 µM 5-(N-ethyl-n-isopropyl)-amiloride (EIPA) to block the activity of Na+/H+ 
exchanger isoform 1 (NHE1).  Villi immobilized by a fine nylon mesh overlay were 
incubated for 5 minutes with a luminal solution containing 100 µM DL-dithiothreitol to 
remove mucus and then incubated on the luminal side with 16 µmol/L of 2’,7’-bis-(2-
carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester BCECF-AM for 10 
minutes before superfusion of the luminal surface.  Using a 40 X water immersion 
objective (Olympus, Melville, NY), epithelial cells from the mid to upper-region of a 
single villus were selected for ratiometric analysis.  Changes in intracellular pH (pHi) 
were measured by dual excitation wavelength technique (440 and 495 nm), and the villi 
were imaged at 535 nm emission.  Ratiometric images were obtained at 20 second 
intervals with a Sensi-Cam digital camera (Cooke, Auburn Heights, MI) and processed 
using Axon Imaging Workbench 2.2 (Axon Instruments, Union City, CA).  The 495 :440 
nm ratios were converted to pHi using a standard curve generated by the K+/nigericin 
technique (12;108).  Intrinsic buffering capacity (βi) of duodenal villous cells was 
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estimated by the ammonium prepulse technique and the total buffering capacity (βtotal) 
was calculated from the equation βtotal = βi + βHCO3- = βi + 2.3 x [HCO3-]i, where βHCO3- is 
the buffering capacity of the HCO3-/CO2 system and [HCO3-]i is the intracellular 
concentration of HCO3-.  The rate of pHi change during the initial 90-s period of linear 
∆pH/∆t change was converted to transmembrane net flux (J) of HCO3- or H+ measured in 
mM/min using the equation J = ∆pH/∆t x βtotal (121).   
Measurement of apical Cl-/HCO3- and Na+/H+ exchange   
 For measurement of Cl-/HCO3- exchange, duodenal preparations were superfused 
with IBR on the luminal side and pHi alkalization was induced by replacement of Cl- with 
isethionate- on an equimolar basis.  After attaining a stable pHi (approximately 2 min), 
pHi recovery was initiated by readdition of Cl- to the luminal superfusate.  In some 
experiments, SO42- was used to replace Cl- on an equimolar basis during pHi recovery.  
For methazolamide studies, 100 µM methazolamide was initially added to the superfusate 
from a 10-mM stock in water.  For bilateral Kreb's bicarbonate Ringer (KBR) studies, the 
luminal superfusate was KBR containing, in mM:  140.0 Na+, 5.2 K+, 25 HCO3-, 5 TES, 
2.8 PO42-, 110 Cl-, 1.2 Ca2+, 1.2 Mg2+, 4.8 gluconate-, 16.8 mannitol, and gassed with 
95% O2/5% CO2 at 37°C (pH 7.4).  The serosal perfusate was similar in composition to 
the luminal solution except 10 mM mannitol was replaced equimolar with glucose.  Rates 
of anion exchange during alkalization and recovery (∆pHi/min) were calculated from a 
linear regression of the values from the first 90 sec of the initial pHi changes during Cl- 
removal and replacement, respectively, and these rates were converted to net J(HCO3-). 
 For measurement of apical membrane Na+/H+ exchange activity, the proximal 
duodenum was superfused with nominally HCO3--free solutions where NaHCO3- was 
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replaced equimolar with NaTES and gassed with 100% O2.  Experiments to measure 
Na+/H+ exchange consisted of pHi acidification induced by replacement of luminal Na+ 
with NMDG+ on an equimolar basis.  After a stable pHi was obtained (approximately 2 
min), pHi recovery was initiated by replacing NMDG+ with Na+.  Rates of anion 
exchange during Na+/H+ exchange were calculated from a linear regression of the values 
from the first 90 sec of the initial pHi changes during Na+ replacement, and these rates 
were converted to net J(H+). 
Studies of recombinant mDRA   
 mDRA (gift of J. Melvin, University of Rochester) was inserted into the multiple 
cloning site of a bicistronic pIRES plasmid (Invitrogen) containing DSRed2, a red 
fluorescent protein (RFP).  The resulting plasmid was transformed into DH5α competent 
cells (Invitrogen) by heat shock and single colonies were picked for plasmid isolation 
(after overnight growth) by the alkaline lysis method.  Plasmid was digested with HincII 
to confirm the proper orientation of the DRA insert.  Plasmid containing mDRA or empty 
vector (control) was transfected using Superfect transfection reagent (Qiagen) according 
to the manufacturer’s directions into Chinese hamster ovary (CHO) cells grown on 
coverslips (50% confluent).  Cells expressing RFP were selected for pHi studies 24 hours 
after transfection. 
Isolation of villous epithelium and RT-PCR   
 Duodenal segments were resected, opened longitudinally along the anti-
mesenteric border and washed in oxygenated, physiologic Ringer’s solution containing 
100 µM dithiothreitol.  Under a dissecting microscope, the segment was placed 
mucosal-side up over a parallel ridge (1 mm height) on a plastic surface and drawn 
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beneath a #11 scalpel blade (perpendicular to the villi), thereby scraping the villous 
epithelium from the villous cores.  The isolated villi were dispersed in a small volume 
(0.5 mL) of oxygenated Ringer’s solution containing (800U/ml) RNAse inhibitor 
(Qiagen) using a large bore transfer pipette and immediately frozen in liquid nitrogen.  
Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.), according 
to manufacturer’s instructions, and dissolved in 100 µl RNAse-free water.  The 
Superscript pre-amplification system (Invitrogen) was used for first-strand cDNA 
synthesis, according to the manufacturer’s instructions.  Each PCR of 25µl contained 1µl 
of cDNA, 1X PCR Mg2+ Free Buffer, 2 mM MgCl2, 0.2 mM dNTP, 0.4 mM primer, and 
0.5 U/rxn Taq DNA polymerase (Promega).  A master mix was made and added to 0.2 ml 
reaction tubes containing either cDNA or water (as RT control).  Primers for DRA, PAT-
1, and AE4 were designed based on murine sequences from the National Center for 
Biotechnology Information (NCBI) database.  Primers for DRA were 5’ 
GGTTTAGCATTTGCTCTGCTGG 3’ and 5’ TTACAGTCATGATGAGTTCGATG 3’.  
Primers for PAT-1 were 5’ GCGACTCTCTGAAAGAGAAGTG 3’ and 5’ 
TCAGAGTTTGGTGGCCAAAACA 3’.  Primers for AE4 were 5’ 
CATGCCTGGTCAAGAAAGCTAG 3’ and 5’ CACTCATGTTACTGGGCCTGGTGG 
3’.  RT-PCR was performed on samples using RT-PCR cycles consisting of a 5.0 min 
denaturation at 94°C followed by 60 cycles of 94°C for 30 sec, 60°C for 1.0 min, and 
72°C for 1.0 min and ended with 7.0 min at 72°C utilizing a MWG Primus 96 plus 
thermocycler (MWG-Biotech Inc., Highpoint, NC).  RT-PCR products were 
electrophoresed on a 2% agarose gel for analysis.  To evaluate genomic DNA 
contamination of the RNA samples, RT-PCR was performed on samples using primers 
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specific for β-actin, 5’ TGTTACCAACTGGGACGACA 3’ and 5’ 
TCTCAGCTGTGGTGGTGAAG 3’.  mRNA expression for each exchanger was 
compared against a similarly-treated tissue control reported to express high levels of the 
specific transcript. 
Western Blot Analysis of NHE3   
 For Western blot analysis, duodenal microsomal membranes were prepared from 
age-matched PAT-1 (-) and WT adult mice as previously described (9;109;120).  Briefly, 
the membrane preparations were separated by SDS-PAGE and transferred to 
nitrocellulose membranes, blocked with 5% milk proteins, and probed with affinity-
purified primary antibodies against NHE3 or β-actin.  The monoclonal anti-NHE3 
antibody was directed against the C-terminal 131 aa of rabbit NHE3 (109), and β-actin 
monoclonal antibodies were purchased from Alpha Diagnostics (San Antonio, TX).  The 
secondary antibody was an anti-rabbit immunoglobulin G (IgG) conjugated to 
horseradish peroxidase (GIBCO BRL, Gaithersburg, Md.), which was visualized using 
chemiluminescence (SuperSignal Substrate, Pierce) and captured on light-sensitive 
imaging film (Kodak). Bands corresponding to NHE3 and β-actin proteins were 
quantified by densitometric analysis (UN-SCAN-IT gel software, Silk Scientific, Inc., 
Orem, Utah, USA) and were expressed as percentages of control. The equity in protein 
loading in all blots was verified by gel staining using Coomassie brilliant blue R-250 
(Bio-Rad, Hercules, CA, USA).   
Materials   
 The fluorescent dye BCECF acetomethyl ester was obtained from Invitrogen 
(Carlsbad, CA).  Tetrodotoxin was obtained from Biomol International L.P. (Plymouth 
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Meeting, PA).  All other materials were obtained from either Sigma Aldrich (St. Louis, 
MO) or Fisher Scientific (Springfield, NJ). 
Statistics   
 All values were reported as mean ± SEM.  Data between two treatment groups 
was compared using a 2-tailed unpaired Student t-test assuming equal variances between 
groups.  A probability value of p < 0.05 was considered statistically significant. 
 
Results 
Expression of DRA, PAT-1, and AE4 in the isolated duodenal villous epithelium   
 DRA, PAT-1, and AE4 previously have been localized to the apical membrane of 
the intestinal epithelia (48;54;120;125).  To verify expression in murine duodenal villi, 
mRNA expression in isolated murine duodenal villi was determined by RT-PCR and 
compared against a tissue control with high expression levels of the particular transcript 
(colon for DRA; kidney for PAT-1 and AE4) (53;54;69;120;124).  As shown in Figure 
3.1, RT-PCR of microdissected villous epithelium from murine duodenum shows 
prominent expression of DRA and PAT-1, and lesser expression of AE4 as compared to 
high-expressing tissue controls. 
Anion exchange in the AE4 (-) upper villous epithelium of murine duodenum   
 Functional studies in Xenopus oocytes indicate that AE4 exhibits Cl/HCO3- 
exchange activity (125).  Therefore, we compared anion exchange activity in the AE4 (-)  
duodenal villous epithelium to that in WT littermate epithelium.  As shown in Figure 
3.2A and B, there is no significant difference in the rates of HCO3- influx during Cl- 
removal (i.e., Cl-out/HCO3-in exchange) and HCO3- efflux during Cl- replacement 
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Figure 3.1.  mRNA expression of DRA, PAT-1, and AE4 in microdissected murine 
duodenal villi.  RT-PCR showing mRNA expression of DRA, PAT-1, and AE4 in 
isolated villous epithelium (v) from WT duodena (representative of 3 experiments).  
Positive tissue controls (tc) are cDNA from cecum (ce) for DRA, and kidney (k) for 
PAT-1 and AE4.  Water (w) and no RT (-) are negative controls.  A single band for β-
actin mRNA indicates minimal contamination of the samples with genomic DNA. 
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(i.e., Cl-in/HCO3-out exchange) in the AE4 (-) as compared to the WT epithelia.  These 
experiments did not detect significant differences in the baseline pHi of the upper villous 
epithelium in the AE4 (-) as compared to the WT (Figure 3.2C).  Anion substitution 
studies in murine duodenal villi have indicated the presence of apical membrane anion 
exchanger(s) that can readily perform SO42-in/HCO3-out exchange (93).  Therefore, we 
examined this property in the AE4 (-) as compared to the WT epithelia.  These studies 
also did not demonstrate a significant difference in the rate of SO42- dependent-HCO3- 
efflux in the AE4 (-) as compared to that in WT duodena (Figure 3.2D).  
Anion exchange in the DRA (-) upper villous epithelium of murine duodenum   
 Previous studies have indicated that DRA is a major contributor to electroneutral 
HCO3- secretion in the duodenum of several species (48); therefore, we examined apical 
Cl-/HCO3- exchange in the DRA (-) upper duodenal villous epithelium.  Cumulative data 
for several pHi experiments on DRA (-) and WT epithelia demonstrate that the rates of 
HCO3- influx during Cl- removal and HCO3- efflux during Cl- replacement are 
significantly reduced in the DRA (-) relative to the WT villi by 30-40% (Figure 3.3A and 
B).  Interestingly, the baseline pHi is significantly increased in the DRA (-) villi under the 
conditions of our study (Figure 3.3C), which may reflect unopposed activity of apical 
Na+/H+ exchange (NHE3) if DRA is coupled to NHE3 for electroneutral NaCl absorption 
in the upper villous epithelium.   
Examination of apical membrane SO4-/HCO3- exchange between the DRA (-) 
epithelium as compared to the WT reveals no significant difference in the rate of SO42--
dependent HCO3- efflux (Figure 3.3D).  These findings suggest that the degree of SO42-
/HCO3- exchange attributable to murine DRA may be minimal as suggested previously 
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Figure 3.2.  Anion exchange activity in the duodenal villous epithelium of WT and AE4 
(-) mice.  A. and B.  Summary of HCO3- influx (A) and HCO3- efflux (B) rates during 
luminal Cl- removal and replacement, respectively, in duodenal villous epithelial cells 
from WT and AE4 (-) mice (n = 5).  Cumulative data show no significant difference 
between the rates of Cl-/HCO3- exchange in the AE4 (-) compared to the WT.  C.  
Summary of baseline pHi in duodenal villous epithelial cells of WT and AE4 (-) mice (n 
= 5).  Cumulative data show no significant difference between the baseline pHi in the 
AE4 (-) compared to the WT.  D.  Summary of SO42- dependent HCO3- efflux rates in 
duodenal villous epithelial cells of WT and AE4 (-) mice (n = 3).  Cumulative data show 
no significant difference between the rate of SO42-/HCO3- exchange in the AE4 (-) 
compared to the WT.   
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Figure 3.3.  Anion exchange activity in the duodenal villous epithelium of WT and DRA 
(-) mice.  A. and B.  Summary of HCO3- influx (A) and HCO3- efflux (B) rates in 
duodenal villous epithelial cells of WT (n = 10) and DRA (-) (n = 7) mice.  The 
cumulative data show a moderate but significant reduction in the rate of Cl-/HCO3- 
exchange following luminal Cl- removal (HCO3- influx) and replacement (HCO3- efflux) 
in the DRA (-) compared to the WT.  C.  Summary of baseline pHi in duodenal villous 
epithelial cells of WT (n = 10) and DRA (-) (n = 7) mice.  Cumulative data show a 
significantly increased baseline pHi in the DRA (-) compared to the WT.  D.  Summary 
of SO42--dependent HCO3- efflux rates in duodenal villous epithelial cells of WT and 
DRA (-) mice (n = 3).  Cumulative data show no significant difference between the rate 
of SO42-/HCO3- exchange in the DRA (-) compared to the WT.  E.  Representative pHi 
trace from mDRA transfected CHO cells during extracellular Cl- removal and 
replacement followed by a second Cl- removal period and extracellular SO42- addition 
(representative of 4 experiments).  Removal of extracellular Cl- resulted in intracellular 
alkalization and re-addition of Cl- led to pHi recovery demonstrating Cl-/HCO3- 
exchange.  However, SO42- replacement following alkalization did not lead to appreciable 
pHi recovery.  *Significantly different from WT. 
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(72).  To investigate this possibility, we expressed recombinant murine DRA (mDRA) in 
CHO fibroblasts.  1As shown by the representative experiment in Figure 3.3E, CHO cells 
expressing mDRA alkalize upon removal of extracellular Cl- and pHi recovery occurs 
upon readdition of extracellular Cl-, thus indicating robust Cl-/HCO3- exchange mediated 
by mDRA.  In contrast, following a second period of pHi alkalization induced by 
extracellular Cl- removal, the pHi does not significantly recover in the presence of 
extracellular SO42-, indicating murine DRA does not efficiently exchange SO42- for 
HCO3-. 
Cl-/HCO3- exchange in the PAT-1 (-) upper villous epithelium of murine duodenum  
 Previous studies conducted in upper murine duodenal villous epithelia revealed 
characteristics of basal anion exchange (e.g., high rates of SO42- transport; enhanced Cl-
/HCO3- exchange activity during epithelial cell depolarization), that were most consistent 
with PAT-1 activity based upon recombinant protein expression studies 
(49;55;93;120;124).  To evaluate the contribution of PAT-1, we compared rates of apical 
membrane Cl-/HCO3- exchange activity between PAT-1 (-) and WT duodenal villi.  As 
shown by the experiment in Figure 3.4A, the rates of alkalization and recovery during Cl- 
substitution/replacement are significantly reduced in PAT-1 (-) compared with WT 
duodenum.  Cumulative data from several pHi experiments on PAT-1 (-) and WT 
epithelia demonstrate that the rates of HCO3- influx during Cl- removal and HCO3- efflux 
during Cl- replacement are significantly reduced by 65 and 80%, respectively in the   
PAT-1 (-) relative to the WT villi (Figure 3.4B and 3.4C).  Paradoxically, the baseline
 
1 No endogenous Cl-/HCO3- exchange was observed in mock transfected CHO cells whereas inconsistent 
levels of activity were found when examining mock-transfected NIH 3T3 and HEK293 cells. 
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Figure 3.4.  Comparison of Cl-/HCO3- exchange activity and baseline pHi and in 
duodenal villous epithelium of WT and PAT-1 (-) mice.  A.  Representative pHi trace of 
WT and PAT-1 (-) duodenal villous epithelial cells during luminal Cl- removal and 
replacement.  B and C.  Summary of HCO3- influx (B) and HCO3- efflux (C) rates in 
duodenal villous epithelial cells from WT and PAT-1 (-) mice (n = 5).  Cumulative data 
show significantly reduced rates of Cl-/HCO3- exchange following luminal Cl- removal 
(HCO3- influx) and replacement (HCO3- efflux) in the PAT-1 (-) compared to WT.  D.  
Summary of baseline pHi in duodenal villous epithelial cells of WT and PAT-1 (-) mice 
(n = 5).  Cumulative data show a significantly reduced baseline pHi in PAT-1 (-) 
compared to WT.  *Significantly different from WT.
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pHi is significantly more acidic in the PAT-1 (-) relative to the WT under the conditions 
of our study. (Figure 3.4D). 
In order to assess the contribution of PAT-1 to SO42-/HCO3- exchange, we 
measured SO42--dependent HCO3- transport rates in duodenal villous epithelium of   
PAT-1 (-) and WT mice.  As shown by the experiment in Figure 3.5A, following pHi 
alkalization induced by luminal Cl- removal, luminal SO42- application resulted in pHi 
recovery in WT villous epithelium.  In contrast, the PAT-1 (-) villous epithelium 
exhibited no discernable pHi recovery with SO42- application.  Cumulative data for 
experiments on PAT-1 (-) and WT epithelia show that the rate of SO42--dependent HCO3- 
efflux (Figure 3.5B) is essentially abolished in the PAT-1 (-) epithelium.  Thus PAT-1 is 
the major anion exchanger responsible for SO42- transport in the murine duodenal villous 
epithelium. 
Investigation of the reduced pHi in the PAT-1(-) upper villous epithelium of the murine 
duodenum   
 As shown in Figure 3.4A and D, baseline pHi is significantly reduced in  
PAT-1 (-) duodenal villous epithelial cells under the conditions of our study.  This result 
was surprising given that PAT-1 is considered a cellular base exporter (119).  We 
hypothesized that the reduced pHi may result from the loss of a coupled interaction 
between PAT-1 and the apical membrane Na+/H+ exchanger NHE3, resulting in 
inhibition of NHE3 expression and/or activity.  Therefore, NHE3 protein expression and 
activity were measured in WT and PAT-1 (-) duodena.  First, as shown in Figure 3.6A,  
Western blot analysis did not indicate that NHE3 protein expression was different 
between PAT-1 (-) and WT duodena.  Second, apical membrane Na+/H+ exchange 
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Figure 3.5.  Comparison of SO42-/HCO3- exchange in the duodenal villous epithelium of 
WT and PAT-1 (-) mice.  A.  Representative pHi trace of WT and PAT-1 (-) duodenal 
villous epithelial cells.  Following alkalization secondary to luminal Cl- removal, SO42- 
was introduced in the luminal superfusate for SO42-in/HCO3-out exchange.  B.  Summary 
of HCO3- efflux rates induced by luminal SO42- application in duodenal epithelial cells 
from WT (n = 3) and PAT-1 (-) (n = 5) mice.  Cumulative data show a significantly 
reduced rate of SO42-/HCO3- exchange in the PAT-1 (-) compared to the WT.  
*Significantly different from WT.   
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activity was measured as the Na+-dependent recovery of pHi after cellular acidification in 
WT and PAT-1 (-) duodenal villi.  These studies revealed no significant difference in the 
rates of Na+/H+ exchange (i.e., H+ efflux) between the PAT-1 (-) and WT duodenal 
villous epithelium (Figure 3.6B), indicating that the acidic pHi in the PAT-1 (-) 
epithelium is not due to loss of NHE3 regulation.  An alternative explanation for the 
acidic pHi is that PAT-1 may act as a HCO3--loading process (Cl-out/HCO3-in) in the 
villous epithelium under the conditions of our studies.  To determine whether the process 
was HCO3- dependent, the baseline pHi was measured in the absence of CO2/HCO3- in the 
PAT-1 (-) and WT.  This maneuver essentially eliminated the difference in baseline pHi 
between the PAT-1 (-) and the WT villous epithelium as shown in Figure 3.7A.  Since 
both a functional and physical relationship between cytosolic carbonic anhydrase CA II 
and PAT-1 has been shown (4;68), we also examined the effect of the carbonic anhydrase 
inhibitor methazolamide (100 µM) on baseline pHi in PAT-1 (-) and WT duodenal villous 
epithelial cells in the presence of CO2/HCO3-.  As shown in Figure 3.7B, methazolamide 
treatment eliminated the difference between the baseline pHi of the PAT-1 (-) and WT 
villous epithelium.  Since isolation of the apical membrane transporters in our studies 
requires inhibition of basolateral transporters including the Na+/K+/2Cl- cotransporter 
NKCC1 and the Cl-/HCO3- exchanger AE2 (with basolateral Cl-- free conditions) and the 
pHi-compensating effects of basolateral NHE1 (with 1 µM EIPA), we asked whether 
removal of this inhibition would normalize pHi in the PAT-1 (-) villous epithelium.  
Initially, the activity of NHE1 was restored by measuring pHi in the absence of  
basolateral EIPA.   As shown in Fig. 3.7C, baseline pHi remains acidic in the PAT-1 (-) 
as compared to the WT epithelium.  Finally, untreated duodenal mucosal preparations 
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Figure 3.6.  Comparison of NHE3 expression and apical membrane Na+/H+ exchange 
activity in WT and PAT-1 (-) small intestine.  A.  (Upper panel) Representative Western 
blot of NHE3 and β-actin protein (as a loading control) in duodenal microsomes of 
gender-matched WT and PAT-1 (-) littermate pairs.  (Lower panel) Densiometric analysis 
of protein expression for NHE3 normalized to expression of β-actin (n = 4 mouse pairs).  
These data show no significant difference of NHE3 protein expression in PAT-1 (-) brush 
border membrane vesicles compared to WT.  B.  Summary of Na+-dependent H+ efflux 
rates in duodenal villous cells of WT and PAT-1 (-) (n = 3) mice.  The cumulative data 
show no significant difference between the rate of Na+/H+ exchange in PAT-1 (-) 
duodenal villi as compared to WT.   
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Figure 3.7.  Baseline pHi studies in the duodenal villous epithelium of WT and PAT-1 (-) 
mice.  A.  Summary of baseline pHi in duodenal villous epithelial cells of WT and PAT-1 
(-) (n = 3) mice in the absence of CO2/HCO3-.  Cumulative data show no significant 
difference in the baseline pHi of PAT-1 (-) as compared to WT.  B.  Summary of baseline 
pHi in duodenal villous epithelial cells of WT and PAT-1 (-) (n = 3) mice when 
performed in the presence of bilateral methazolamide (100 µM) to inhibit carbonic 
anhydrase activity.  Cumulative data show no significant difference in the baseline pHi of 
PAT-1 (-) as compared to WT.  C.  Summary of baseline pHi in duodenal villous 
epithelial cells of WT and PAT-1 (-) (n = 5) mice when performed in the absence of 
serosal EIPA.  Cumulative data show a significantly reduced baseline pHi in PAT-1 (-) 
compared to WT.  D.  Summary of baseline pHi in duodenal villous epithelial cells of 
WT and PAT-1 (-) (n = 3) mice when performed with bilateral KBR.  Cumulative data 
show no significant difference in baseline pHi of PAT-1 (-) as compared to WT under 
physiologic conditions.  *Significantly different from WT. 
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were superfused with a physiologic Kreb’s bicarbonate Ringer’s solution (KBR) 
bilaterally.  These studies revealed that under physiologic conditions, pHi was similar 
between PAT-1 (-) and WT epithelium (Fig. 3.7D). 
 
Discussion 
 The process of basal HCO3- secretion across the duodenum has been shown in 
several species to principally involve the activity of apically located Cl-/HCO3- 
exchanger(s) (25;84;99).  Therefore, in an effort to resolve the identity of the anion 
exchangers involved in these processes, we examined the anion exchange properties in 
epithelial cells located on the upper one-half of duodenal villi in murine knockout models 
with deletions of the apical membrane transporters, PAT-1, DRA, and AE4 
(48;54;120;125).  RT-PCR of isolated murine duodenal villi demonstrated the expression 
of PAT-1 and DRA, and a low level of AE4 expression.  Phenotypically, investigations 
of PAT-1 (-) (119) and AE4 (-) (G.E. Shull, unpublished observations) mice have 
revealed no overt disease and normal growth rates.  In contrast, the DRA (-) mice have 
chronic mild diarrhea (i.e., soft feces), a propensity to rectal prolapse, decreased body 
weights, and a mortality rate that exceeds that of the PAT-1 (-) and AE4 (-) mice (17).  In 
the present investigation, BCECF microfluorimetry studies of intact PAT-1 (-) duodena 
revealed that apical Cl-/HCO3- exchange was significantly reduced by 65-80% as 
compared to WT.  This finding confirms our previous study that revealed characteristics 
of anion exchange in the upper villus of the murine duodenum that were most consistent 
with PAT-1activity,  [i.e., capability for SO42-/HCO3- exchange; an increased rate of 
Clout/HCO3-in exchange during membrane consistent with the proposed stoichiometry of 
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PAT-1 (1 Cl-/>2 HCO3-)] (93). In addition to PAT-1, a finite rate of Cl-/HCO3- exchange 
was still present in the PAT-1 (-) duodena, indicating the contribution of other anion 
exchangers such as DRA and AE4.  Examination of AE4 (-) as compared to WT mice 
revealed minimal involvement of the AE4 anion exchanger to basal Cl-/HCO3- exchange 
in the upper villous epithelium.  In contrast, examination of Cl-/HCO3- exchange activity 
in DRA (-) as compared to WT mice demonstrated a 30-40% reduction in exchange rates.  
Thus these data indicate that PAT-1 is the principal Cl-/HCO3- exchanger in the apical 
membrane of the upper villous epithelium with a smaller but significant contribution by 
DRA, and minimal contribution from AE4.   
The present investigation found that a distinguishing feature of PAT-1 is its 
ability to transport SO42- because SO42-/HCO3- exchange is essentially eliminated in the 
PAT-1 (-) villous epithelium as compared to WT.  Both PAT-1 and DRA have been 
reported to be sulfate transporters (72); however, recent studies utilizing recombinant 
protein expression systems have shown that human DRA does not efficiently transport 
SO42-, i.e., the rate of SO42- transport is 2-3 orders of magnitude less than the rate of Cl-
/HCO3- exchange (20;72).  In the present study, SO42-/HCO3- exchange in the DRA (-) 
duodenal villus was not significantly different from that observed in WT villi indicating 
that murine DRA also does not transport SO42-.  To verify that murine DRA like human 
DRA does not effectively transport SO42-, we measured SO42-/HCO3- exchange activity of 
recombinant mDRA expressed in CHO fibroblasts.  These studies revealed a robust Cl-
/HCO3- exchange but little evidence of SO42-/HCO3- exchange in mDRA transfected cells.  
In addition, examination of SO42- transport in the surface epithelium of the cecum where 
DRA is the dominant apical membrane exchanger also revealed no detectable SO42- 
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transport (data not shown).  Rates of SO42-/HCO3- exchange were also measured in the 
AE4 (-) duodenal villous epithelium since studies examining AE4 exchange properties 
are limited (125).  Like the studies with DRA (-) epithelium, these experiments revealed 
no significant difference in the SO42--dependent HCO3- efflux in the AE4 (-) as compared 
to WT villous epithelium.  Thus, the data show that a distinguishing characteristic of 
PAT-1 is the capability for SO42-/HCO3- exchange in the upper villous epithelium of 
murine duodenum. 
 Measurements of pHi in the DRA (-) and PAT-1 (-) villous epithelium revealed 
opposite effects of these transporters on pHi regulation.  In the DRA (-) villous 
epithelium, baseline pHi was significantly increased as compared to WT.  This change is 
consistent with loss of a Cl-/HCO3- exchanger that is normally coupled to the Na+/H+ 
exchanger NHE3 for electroneutral NaCl absorption, i.e., continued proton efflux via 
NHE3 without concurrent HCO3- efflux would increase pHi.  Additional studies of DRA 
(-) mice using jejunum, where electroneutral NaCl absorption predominates, will be 
necessary to test this hypothesis.  In contrast to the deletion of DRA, measurements of 
pHi in the PAT-1 (-) villous epithelium revealed a significantly reduced baseline pHi as 
compared to WT.  This phenomenon was investigated further because cell acidification 
resulting from deletion of a base-exporter is counterintuitive.  One potential explanation 
is that loss of a coupled interaction between PAT-1 and NHE3 reduces the activity or 
expression of the Na+/H+ exchanger.  However, apical membrane Na+/H+ exchange 
activity and NHE3 protein expression were not different between PAT-1 (-) and WT 
epithelia.  An alternative hypothesis is that PAT-1 acts as a base importer (i.e., Cl-
out/HCO3-in exchange) under the conditions of our study.  Consistent with this hypothesis 
was the demonstration that removal of CO2/HCO3- from the superfusate media 
normalized pHi in the PAT-1 (-) and WT epithelium.  Based on evidence that PAT-1 may 
functionally and physically interact with carbonic anhydrase II (4), the latter finding 
suggests a novel interaction between PAT-1 and intracellular carbonic anhydrase, i.e., the 
“HCO3- transport metabolon” (68;102) that facilitates HCO3- influx to protect the 
epithelial cell against intracellular acidification.  This may be of physiologic importance 
as the upper villous epithelium of the duodenum is exposed to acid challenge not only 
from gastric effluent, but also from H+ influx during nutrient absorption (e.g., the apical 
H+/peptide cotransporter PEPT1) (28).  However, this hypothesis will need to be tested 
further during luminal acid exposure and PEPT1-mediated transport in the duodenal 
villous epithelium.  Isolation of apical membrane acid-base transporters required 
inhibition of basolateral NHE1 by EIPA treatment and Cl-/HCO3- exchange by removal 
of basolateral Cl-, respectively.  We first investigated whether the activity of NHE1 could 
normalize basal pHi in the PAT-1 (-) epithelium by removing basolateral EIPA treatment.  
However, the PAT-1 (-) villous epithelium remained acidic as compared to the WT 
indicating that activity of NHE1 alone is apparently unable to compensate for the loss of 
PAT-1.  Next, a physiological Cl- concentration was included in the basolateral bath in 
addition to removing basolateral EIPA treatment.  These changes resulted in the 
correction of the pHi difference between the PAT-1 (-) and WT villous epithelium.  Thus, 
under physiological conditions, pHi of the upper villous epithelium can be normalized in 
the absence of PAT-1 by a complex process apparently requiring the activity of 
basolateral transporters. 
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Basal HCO3- secretion by the duodenum is largely mediated by the activity of 
anion exchangers and reduced rates of secretion have been reported for CF patients and 
CF mouse models (83;84).  Consistent with these findings, our previous studies of the 
CFTR (-) mouse intestine found that rates of apical membrane Cl-/HCO3- are reduced in 
the upper villous epithelium.  The mechanism of the decrease was traced to the loss of a 
CFTR-mediated Cl- “leak” pathway that effluxes Cl- entering via an apical Cl-/HCO3- 
exchanger (93).  This conclusion followed from studies showing that 1) increased anion 
exchanger activity in wild-type (WT) duodenum was supported only by transport of 
CFTR-permeant anions (Cl- and NO3- but not SO42-), and 2) glybenclamide blockade of 
CFTR reduced the rate of Cl-/HCO3- exchange in WT epithelium to a level equivalent 
with CFTR(-) epithelium.  Based upon the present data, it is reasonable to conclude that 
the CFTR Cl- leak primarily facilitates PAT-1 function in the upper villous epithelium.  
However, loss of CFTR facilitation of PAT-1 activity may represent only one component 
of reduced basal HCO3- secretion in the CF intestine.  Recent pH stat studies of PAT-1 (-) 
mouse duodenum estimate that PAT-1 contributes only 20% to basal HCO3- secretion in 
WT duodenum (114).  Since the present studies were confined to the upper villous 
epithelium, most HCO3- secretion under basal conditions apparently comes from the 
lower villous and crypt epithelium where the activities of DRA or AE4 may provide a 
major contribution to basal HCO3- secretion. 
In conclusion, our studies of PAT-1, DRA, and AE4 (-) mice indicate that PAT-1 
is the major contributor to basal Cl-/HCO3- and SO42-/HCO3- exchange across the apical 
membrane of epithelial cells in the upper villous epithelium of the duodenum.  Based on 
past studies of CFTR activity in this region of the villus, it is likely that PAT-1 activity is 
 78
facilitated indirectly by a CFTR Cl- “leak” pathway that sustains the driving force for Cl-
/HCO3- exchange.  However, additional studies of the PAT-1 (-) duodenum revealed a 
propensity for PAT-1 to operate in Cl-out/HCO3-in mode for HCO3- influx, thereby 
providing a potentially important mechanism for protecting the upper villous epithelial 
cell from intracellular acidification during exposure to luminal acid.  DRA was also 
found to contribute a smaller but significant portion of Cl-/HCO3- exchange in the upper 
villous epithelium.  DRA deletion resulted in intracellular alkalization which may be 
indicative of DRA’s involvement in coupled NaCl absorption in this locale. Therefore, 
DRA in the upper villous epithelium may not significantly contribute to net HCO3- 
secretion under basal conditions.  Nonetheless, it will be necessary to examine anion 
transport in the lower villus/crypt epithelium where CFTR is predominantly expressed in 
order to fully evaluate the contributions of AE4, DRA, and PAT-1 to transepithelial 
bicarbonate secretion. 
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Chapter 4 
INHIBITION OF PAT-1 IMPAIRS THE ABILITY OF UPPER VILLOUS 
EPITHELIAL CELLS OF THE MURINE DUODENUM TO REGULATE pHi 
DURING H+-DIPEPTIDE TRANSPORT 
 
 
Introduction 
 The small intestinal enterocyte is the principal site for the absorption of dietary 
proteins that have been degraded enzymatically to free amino acids and small peptides.  
The majority of protein digestion products are absorbed in the form of di- and tripeptides 
by the intestinal oligopeptide transporter PEPT1 (28).  PEPT1 expression is restricted to 
the apical membrane of the small intestine with greatest levels in the duodenum and 
jejunum where it is not detectable in the crypts but increases from the villous base to its 
highest levels in the villous tips (38).  The PEPT1 protein has the ability to transport all 
the 400 different dipeptides and 8000 different tripeptides derived from luminal protein 
digestion regardless of net charge, molecular size, and solubility (57).  In addition, many 
orally delivered drugs which have dipeptide and tripeptide structures, including β-lactam 
antibiotics and ACE inhibitors, and bacterial products, such as f-MLP and muramyl 
dipeptide, cross the absorption barrier by means of transport through PEPT1 
(15;38;70;116). 
 Transport via PEPT1 is electrogenic and is coupled to an inwardly directed proton 
gradient that allows for transport of peptides against a concentration gradient (65).  
H+/peptide influx exhibits a stoichiometry of 1:1, which occurs irrespective of the net 
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charge associated with the peptide, but there is a clear preference for non-charged species 
(57).  Studies of intestinal cell lines have shown that proton di-/tripeptide uptake results 
in intracellular acidification, and this decrease in pHi will diminish the driving force for 
PEPT1-mediated transport unless the proton load is reduced by means of intracellular 
buffering or proton efflux (110;111).  Therefore, optimal peptide absorption must rely 
upon the coordination of a number of acid-base transport proteins present in intestinal 
epithelial cells.  Studies performed in the absence of CO2/HCO3- have revealed that the 
intracellular acidification resulting from PEPT1-mediated transport can be effectively 
minimized by means of apical membrane Na+/H+ exchange activity (i.e., NHE2 and 
NHE3) (50;94;112;113) .  Further, in intestinal cell lines endogenously expressing 
PEPT1 and Na+/H+ exchanger proteins, it has been shown that PEPT1-mediated transport 
activates NHE3, the major  Na+/H+ exchanger in the mammalian intestine (50;112;113).  
As a result, H+ can recycle across the apical membrane maintaining pHi and the driving 
force for peptide absorption.  Under physiologic conditions, (i.e., in the presence of 
CO2/HCO3-), one previous study performed in murine small intestinal villous epithelia 
has demonstrated that intracellular carbonic anhydrase (CA) activity facilitates diffusive 
H+ movement thereby maintaining a transmembrane ion gradient that allows for maximal 
absorption via PEPT1 (103).  However, the contribution of acid-base transporters to the 
regulation of pHi during H+ peptide transport has not been fully investigated under 
physiologic conditions.   
 In addition to Na+/H+ exchangers and carbonic anhydrase, Cl-/HCO3- exchangers 
contribute to acid/base transport across duodenal villous epithelium.  Three anion 
exchangers that allow for Cl-/HCO3- exchange have been localized to the apical 
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membrane in murine duodenum:  down-regulated in adenoma (DRA, Slc26a3), the 
putative anion transporter-1 (PAT-1, Slc26a3), and anion exchanger 4 (AE4, Slc4a9) 
(48;54;120;125).  In a recent study on mice with gene-targeted deletions of these 
exchangers, PAT-1 has been shown to be the dominant Cl-/HCO3- exchanger in the apical 
membrane of epithelial cells in the upper half of the duodenal villi (Chapter 3), the site of 
primary expression for PEPT1 (38).  However, recent pH stat studies in the PAT-1 (-) 
murine duodenum indicate that PAT-1 contributes only 20% to transepithelial basal 
bicarbonate secretion (114;119).  In addition, pHi measurements under conditions that 
isolate apical membrane acid-base transport in the PAT-1 (-) villous epithelium have 
revealed a significantly reduced baseline pHi as compared to WT, a difference that is 
HCO3--dependent (Chapter 3).  This finding indicates a propensity for PAT-1 to act as a 
base importer (i.e., Cl-out/HCO3-in) in native villous epithelium.  The ability of PAT-1 to 
function as a base importer may be physiologically relevant as the upper villous 
epithelium of the duodenum is exposed to acid challenge not only from gastric effluent, 
but also from H+ influx during nutrient absorption, e.g., PEPT1-mediated absorption.  
Furthermore, PAT-1 has been shown to physically and functionally interact with 
cytosolic CAII, the most widely expressed isozyme of the small intestine (4).  Therefore, 
we investigated the relative contributions of PAT-1 and CAII in the process of pHi 
regulation in the duodenal upper villous epithelium during absorption of the PEPT1-
dipeptide substrate glycyl-sarcosine (Gly-Sar) using mice with gene-targeted deletions of 
PAT-1 and CAII and their wild-type (WT) littermates.  
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Materials and Methods 
Animals   
 The experiments in this study were performed on mice with gene-targeted 
disruptions of the murine homologs of PAT-1 (119) and CAII (98).  All comparisons 
were made with gender- and age-matched (+/+) siblings (WT).  The mutant mice were 
identified using a PCR based analysis of tail snip DNA, as previously described (24).  All 
mice were maintained ad libitum on standard laboratory chow (Formulab 5008 Rodent 
Chow; Ralston Purina) and tap water.  The mice were housed singly in a temperature (22-
26°C) and light (12:12-h light-dark cycle)-controlled room in the AAALAC accredited 
animal facility at the Dalton Cardiovascular Research Center.  Intestinal tissues for 
experiments were obtained from mice 2-4 months of age.  These mice were fasted 
overnight prior to experimentation but were provided with water ad libitum.  All 
experiments involving animals were approved by the University of Missouri Animal Care 
and Use Committee. 
Short-circuit current measurement   
 Freshly-excised duodenum or jejunum from WT mice was stripped of the 
underlying muscle layers and mounted on voltage-clamped Ussing chambers for the 
measurement of short-circuit current (Isc) as previously described (25).  The apical 
surface of the duodenum was bathed with Kreb’s bicarbonate Ringers (KBR) containing 
in mM:  140.0 Na+, 5.2 K+, 2.8 PO42-, 119.8 Cl-, 25.0 HCO3-, 1.2 Ca2+, 1.2 Mg2+, 4.8 
gluconate-, 10.0 mannitol, 1 µM indomethacin and gassed with 95% O2: 5% CO2 at 37°C 
(pH 7.4).  The basolateral perfusate was similar in composition to the apical solution 
except 10 mM mannitol was replaced equimolar with glucose and contained 1 µM 
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indomethacin, and 0.1 µM tetrodotoxin.  Prior to experimentation, the apical surface of 
the tissue was treated with 100 µM 5-(N-ethyl-n-isopropyl)-amiloride (EIPA) or 100 µM 
niflumic acid (NFA) from a 100 mM stock in DMSO.  Following a 20 min equilibration 
period, 20 mM Gly-Sar was added to the luminal bath, and the change in Isc was recorded 
after five minute intervals.  
Fluorescence Measurement of Intracellular pH and Image Analysis   
 The method used for imaging villous epithelial cells in intact murine intestine has 
been previously described (39;93).  Briefly, after euthanasia of the mouse, the proximal 
duodenum or jejunum was isolated, stripped of the outer muscle layers by blunt 
dissection and mounted luminal side up in a horizontal Ussing-type perfusion chamber 
where luminal and serosal surfaces of the tissue were independently bathed.   All tissues 
were treated with indomethacin (1 µM) bilaterally and tetrodotoxin (TTX, 0.1 µM) 
serosally to minimize the effect of endogenous prostaglandins and neural tone, 
respectively.  Villi immobilized by a fine nylon mesh overlay were incubated for 5 
minutes with a KBR or isethionate- bicarbonate Ringer (IBR) luminal solution containing 
100 µM DL-dithiothreitol to remove mucus and followed by incubation on the luminal 
side with 16 µmol/L of 2’,7’-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein 
acetoxymethyl ester (BCECF-AM) for 10 minutes.  Using a 40 X water immersion 
objective (Olympus, Melville, NY), 10 epithelial cells from the mid to upper-region of a 
single villus were selected for ratiometric analysis.  Changes in intracellular pH (pHi) 
were measured by the dual excitation wavelength technique (440 and 495 nm), and 
imaged at 535 nm emission.  Ratiometric images were obtained at 20 second intervals 
with a Sensi-Cam digital camera (Cooke, Auburn Heights, MI) and processed using Axon 
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Imaging Workbench 2.2 (Axon Instruments, Union City, CA).  The 495: 440 nm ratios 
were converted to pHi using a standard curve generated by the K+/nigericin technique 
(12;108).  Intrinsic buffering capacity (βi) of duodenal villous cells was estimated by the 
ammonium prepulse technique and the total buffering capacity (βtotal) was calculated from 
the equation βtotal = βi + βHCO3- = βi + 2.3 x [HCO3-]i, where βHCO3- is the buffering 
capacity of the HCO3-/CO2 system and [HCO3-]i is the intracellular concentration of 
HCO3- (121).  The rate of pHi change during the initial 90-s period of linear ∆pH/∆t 
change was converted to transmembrane net flux (J) of HCO3- or H+ measured in 
mM/min using the equation J = ∆pH/∆t x βtotal.   
Measurement of Gly-Sar induced H+ influx  
 For studies measuring Gly-Sar induced H+ influx, the luminal superfusate was a 
KBR solution containing (in mmol/L): 140.0 Na+, 110.0 Cl-, 25.0 HCO3-, 5.2 K+, 5.0 N-
tris methyl-2-aminoethanesulfonic acid (TES), 4.8 gluconate-, 2.8 PO42-, 1.2 Ca2+, 1.2 
Mg2+, and 16.8 mannitol that was gassed with 95% O2: 5% CO2 at 37°C (pH 7.4).  The 
serosal perfusate was similar in composition to the luminal solution except 10 mM 
mannitol was replaced equimolar with glucose.  After attaining a stable pHi measurement 
(approximately 2 min), the tissue was exposed to 20 mM Gly-Sar on the luminal side.  
Following measurement of Gly-Sar-induced acidification, pHi recovery was induced by 
removing Gly-Sar from the luminal superfusate.  For methazolamide studies, 100 µM 
methazolamide was initially added to the luminal and serosal perfusates from a 10 mM 
stock in water.  In HCO3--free studies, a TES buffered Ringer (TBR) was used in which 
25 mM HCO3- was replaced with 25 mM TES, and the luminal and serosal solutions were 
gassed with 100% O2.  For inhibitor studies, 100 µM EIPA or 100 µM NFA was added to 
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the luminal superfusate from a 100 mM stock in DMSO.  For Cl- free studies, Cl- was 
replaced equimolar with isethionate-.  Rates of Gly-Sar-induced acidification and 
recovery (∆pHi/min) were calculated from a linear regression of the values from the first 
90 sec of the initial pHi changes during luminal Gly-Sar addition and removal, 
respectively. 
Measurement of apical Cl-/HCO3- exchange  
 For studies measuring Cl-/HCO3- exchange in the murine duodenal preparations, 
the luminal superfusate was an IBR solution containing (in mmol/L): 140.0 Na+, 55.0 Cl-, 
55.0 isethionate-, 25.0 HCO3-, 5.2 K+, 5.0 TES, 4.8 gluconate-, 2.8 PO42-, 1.2 Ca2+, 1.2 
Mg2+, 10.0 glucose, and 6.8 mannitol that was gassed with 95% O2: 5% CO2 at 37°C (pH 
7.4).  The serosal superfusate was a Cl--Free IBR (Cl- replaced with isethionate) gassed 
with 95% O2: 5% CO2 at 37°C (pH 7.4).  Duodenal preparations were superfused with 
IBR on the luminal side and pHi alkalization was induced by replacement of Cl- with 
isethionate- on an equimolar basis.  After attaining a stable pHi measurement 
(approximately 2 min), pHi recovery was initiated by readdition of Cl- to the luminal 
superfusate.  For Gly-Sar studies, 20 mM Gly-Sar was added to the luminal superfusate.  
For methazolamide studies, 100 µM methazolamide was initially added to luminal and 
serosal superfusates from a 10 mM stock in water.  Rates of anion exchange during 
alkalization and recovery (∆pHi/min) were calculated from a linear regression of the 
values from the first 90 sec of the initial pHi changes during Cl- removal and 
replacement, respectively. 
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Materials   
 The fluorescent dye BCECF acetoxymethyl ester was obtained from Invitrogen 
(Carlsbad, CA).  Tetrodotoxin was obtained from Biomol International L.P. (Plymouth 
Meeting, PA).  All other materials were obtained from either Sigma Aldrich (St. Louis, 
MO) or Fisher Scientific (Springfield, NJ). 
Statistics   
 All values are reported as mean ± SEM.  Data between two treatment groups were 
compared using a 2-tailed unpaired Student t-test assuming equal variances between 
groups.  Data from multiple treatment groups were compared using a one-way analysis of 
variance with a post hoc Tukey’s t-test.  A probability value of p < 0.05 was considered 
statistically significant. 
 
Results 
The role of apical Na+/H+ exchangers in peptide absorption under physiologic conditions  
  In the absence of CO2/HCO3- in the medium, the apical membrane Na+/H+ 
exchangers NHE3 and NHE2 can effectively minimize pHi acidification during proton di-
/tripeptide transport (50;94;112;113).  However, relatively little is currently known 
regarding the role of apical membrane Na+/H+ exchangers in pHi maintenance during 
peptide absorption under physiologic conditions (i.e., in the presence of CO2/HCO3-).  
Therefore, we investigated transepithelial absorption of Gly-Sar, a non-metabolized 
dipeptide substrate for PEPT1, as indexed by Isc across the murine duodenum.  As shown 
in Figure 4.1A, these studies demonstrate that robust Gly-Sar absorption occurs under 
physiologic conditions, and that with apical application of 100 µM EIPA, a reduced but 
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substantial amount of dipeptide absorption persists.  To further investigate pHi regulation 
during dipeptide uptake under physiologic conditions, pHi of murine duodenal villous 
epithelial cells was measured in the presence and absence of CO2/HCO3-.  In HCO3--free 
conditions (i.e., TBR), addition of 20 mM Gly-Sar to the luminal bath results in 
intracellular acidification (H+ influx) as H+ is transported along with Gly-Sar into the cell 
via PEPT1 (Figure 4.1B and 1C).  Following removal of Gly-Sar from the luminal bath, 
pHi returns toward baseline value in the villous epithelium (Figure 4.1B).  In contrast, 
under physiologic conditions (i.e., KBR), villous epithelia exhibit minimal H+ influx with 
luminal Gly-Sar addition.  Furthermore, with apical application of 100 µM EIPA to 
inhibit NHE2 and NHE3 activity, minimal H+ influx is observed (Figure 4.1C).  Taken 
together, these data indicate that, under physiologic conditions, villous epithelia are able 
to maintain stable pHi allowing for sustained peptide absorption by mechanisms other 
than H+ efflux via apical membrane Na+/H+ exchange. 
Involvement of carbonic anhydrase II in pHi regulation during peptide absorption   
 A previous study has shown that carbonic anhydrase functions in small intestinal 
enterocytes to facilitate intracellular acid diffusion during H+/dipeptide transport (103).  
Therefore, we investigated the role of carbonic anhydrase activity in the regulation of pHi 
during luminal peptide absorption.  First, pHi was measured in murine duodenal villous 
epithelial cells in the presence of methazolamide to inhibit the activity of both 
intracellular and extracellular carbonic anhydrases.  As shown in Figure 4.2A and B, the 
rates of H+ influx and efflux during luminal Gly-Sar addition and removal, respectively, 
are significantly increased in the methazolamide-treated as compared to vehicle control.  
To investigate the specific CA involved in pHi regulation during peptide absorption, 
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Figure 4.1.  Measurement of H+/peptide absorption and H+/peptide-induced acidification 
in murine duodena during inhibition of apical Na+/H+ exchange.  A.  Transepithelial Gly-
Sar absorption as indexed by short circuit current (Isc) for WT duodena in the presence (n 
= 5) or absence of 100 µM EIPA (n = 8) to inhibit apical Na+/H+ exchange.  Cumulative 
data show that under physiologic conditions (i.e., in the presence of CO2/HCO3-), robust 
Gly-Sar absorption occurs, and with apical application of EIPA, a reduced but substantial 
amount of Gly-Sar absorption persists. *Significantly different from vehicle control.  B.  
Representative trace of pHi in the absence of CO2/HCO3- (i.e., TBR) in WT duodenal 
villous epithelial cells during luminal addition and removal of Gly-Sar.  Addition of Gly-
Sar results in intracellular acidification as H+ is transported along with Gly-Sar into the 
cell through PEPT1.  Following removal of Gly-Sar from the luminal bath, a recovery in 
the pHi of the villous epithelia is observed.  C.  Comparison of H+ influx rates during 
apical Gly-Sar addition for WT duodenal villous epithelia in TBR (n = 6), under 
physiologic conditions (i.e., KBR) (n = 3), and in KBR with luminal addition of 100 µM 
EIPA (i.e., KBR + 100 µM EIPA) (n = 3).  Cumulative data show that in TBR, duodenal 
villous epithelial cells acidify in response to Gly-Sar uptake; however, in KBR and KBR 
+EIPA, villous epithelia exhibit minimal H+ influx with apical Gly-Sar addition.   
a,bMeans with the same letters are not  statistically different.  
 
 
 
 
 
Figure 4.1 
Time (min)
-5 0 5 10 15 20
µA
/c
m
²
-140
-120
-100
-80
-60
-40
-20
0
20
vehicle
100µM EIPA 
Gly-sar
Isc
*
* *
H+ Influx
m
M
/m
in
-5
-4
-3
-2
-1
0
a
b
b
TBR
KBR
KBR + EIPA
Time (s)
0 200 400 600 800
pH
i
7.0
7.2
7.4
7.6
7.8
8.0 Gly-SarAp
A
C
B
 
 89
 90
Figure 4.2.  Regulation of pHi during Gly-Sar uptake during inhibition of carbonic 
anhydrases.  A and B.  Summary of H+ influx (A) and H+ efflux (B) rates for WT 
duodenal villous epithelial cells in the presence (n = 3) or absence of 100 µM 
methazolamide (n = 3) to inhibit carbonic anhydrases during luminal addition and 
removal of Gly-Sar.  The cumulative data show a significant acidification (H+ influx) 
during luminal Gly-Sar application in the presence of methazolamide; and following Gly-
Sar removal the villous epithelial cells do exhibit a significant rate of pHi recovery (H+ 
efflux).  *Significantly different from vehicle control.  C and D.  Summary of H+ influx 
(C) and H+ efflux (D) rates for jejunal villous epithelial cells from WT and CAII (-) mice 
(n = 4) during luminal addition and removal of Gly-Sar.  Cumulative data show a 
significant acidification (H+ influx) during luminal Gly-Sar application in the CAII (-) 
compared to the WT, and following Gly-Sar removal the CAII (-) villous epithelial cells 
do exhibit a significant rate of pHi recovery (H+ efflux).  *Significantly different from 
WT.   
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studies were then performed utilizing small intestine from mice lacking the cytosolic 
carbonic anhydrase II (CAII), the major isozyme of the villous epithelium (78).  As 
shown in Figure 4.2C, small intestinal villous epithelia of CAII (-) mice demonstrate an 
impaired ability to maintain pHi, as evidenced by an increased rate of H+ influx upon 
luminal Gly-Sar addition as compared to WT.  Following removal of Gly-Sar from the 
luminal bath, a complete recovery of the pHi was observed in the CAII (-) villous 
epithelium (Figure 4.2D).  The above studies indicate that CAII by regulating the 
reversible hydration of CO2 facilitates the rate of H+ movement within the enterocyte 
during peptide absorption.   
Role of apical membrane Cl-/HCO3- exchange in the pHi regulation during peptide 
absorption   
 Previous studies have shown high levels of expression and functional activity of 
Slc26a Cl-/HCO3- exchangers in the villous epithelium of the upper small intestine 
(Chapters 2 and 3).  Therefore, we investigated the contribution of apical membrane Cl-
/HCO3- exchange to H+ dipeptide absorption.  Transepithelial absorption of Gly-Sar as 
indexed by Isc in the murine jejunum was measured during inhibition of apical membrane 
Cl-/HCO3- exchange with apical application of 100 µM NFA, a dose previously shown to 
inhibit approximately 60% of villous Cl-/HCO3- exchange NFA (Chapter 2) (Figure 
4.3A).  These results demonstrate that, under physiologic conditions, a significant 
reduction in Gly-Sar absorption (~70%) occurs in the presence of NFA compared to 
vehicle control.  To investigate the role of Cl-/HCO3- exchange activity during luminal 
peptide absorption, we performed studies to measure pHi during the inhibition of apical 
membrane Cl-/HCO3- exchange by Cl- substitution or NFA treatment.   
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Figure 4.3.  Regulation of pHi during Gly-Sar uptake and H+/peptide absorption in 
murine duodena during inhibition of apical Cl-/HCO3- exchange.  A.  Transepithelial Gly-
Sar absorption as indexed by Isc for WT duodena in the presence or absence of NFA (n = 
4) to inhibit apical Cl-/HCO3- exchange.  Cumulative data show a significant reduction in 
Gly-Sar absorption with apical application of NFA compared to control.  *Significantly 
different from vehicle control.  B and C.  Summary of H+ influx (B) and H+ efflux (C) 
rates for WT duodenal villous epithelial cells during apical Gly-Sar addition for WT 
duodenal villous epithelia in KBR, in the absence Cl- bilateral (Cl- Free (bi)), and in the 
presence of NFA (n = 3).  Cumulative data show in Cl- Free (bi) a significantly increased 
rate of acidification (H+ influx) with luminal Gly-Sar addition as compared to KBR, and 
luminal application of NFA results in an acidification rate intermediate to that observed 
with KBR and Cl- free conditions.  With luminal Gly-Sar removal an equivalent rate of 
pHi recovery (H+ efflux) was observed under both Cl- free (bi) and NFA conditions.  
a,b,cMeans with the same letters are not statistically different.  
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As shown in Figure 4.3B, in the absence of Cl-, duodenal villous epithelia exhibit a 
significantly increased rate of acidification with apical Gly-Sar addition as compared to 
KBR.  Apical application of NFA results in an acidification rate intermediate to that 
observed with KBR and Cl- free conditions.  Following Gly-Sar removal from the 
luminal bath, an equivalent rate of pHi recovery is observed during inhibition of Cl-
/HCO3- exchange with bilateral Cl-- free conditions or during apical NFA treatment 
(Figure 4.3C). 
Role of apical membrane PAT-1 in pHi regulation during peptide absorption   
 Previous studies have demonstrated that PAT-1 is the primary apical membrane 
Cl-/HCO3- exchanger in the upper villus of the duodenum and that it may principally act 
as a HCO3- importer (Chapter 3).  Furthermore, separate studies have revealed that 
cytosolic CAII can physically and functionally interact with PAT-1 (4).  Therefore, we 
next examined the specific involvement of PAT-1 during PEPT1 transport.  Utilizing 
duodena from mice deficient for PAT-1, small intestinal villous epithelia of PAT-1 (-) 
mice demonstrate a significantly reduced pHi (Fig. 4.4A) and an increased rate of H+ 
influx with luminal Gly-Sar addition as compared to WT (Fig. 4.4B), and following 
removal of Gly-Sar from the luminal bath, a partial recovery of the pHi is observed in the 
PAT-1 (-) villous epithelium (Fig. 4.4C). 
Specific effect of Gly-Sar absorption on apical membrane Cl-/HCO3- exchange activity in 
duodenal villous epithelium   
 To examine the role of PAT-1 in regulating pHi during Gly-Sar absorption, the 
rate of Cl-/HCO3- exchange was measured in the presence of luminal Gly-Sar.  First, 
studies of WT upper duodenal villous epithelium reveal that the mean rate of  
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Figure 4.4.  Comparison of baseline pHi and pHi regulation in duodenal villous 
epithelium of WT and PAT-1 (-) mice during Gly-Sar absorption.  A.  Summary of 
baseline pHi in duodenal villous epithelial cells of WT and PAT-1 (-) (n = 4) mice during 
luminal Gly-Sar exposure.  Cumulative data show a significantly reduced baseline pHi in 
the PAT-1 (-) compared to the WT.  B and C.  Summary of H+ influx (B) and H+ efflux 
(C) rates for duodunal villous epithelial cells from WT and PAT-1 (-) (n = 3) mice during 
luminal addition and removal of Gly-Sar.  Cumulative data show a significant 
acidification (H+ influx) during luminal Gly-Sar application in the PAT-1 (-) compared to 
the WT, and following Gly-Sar removal the PAT-1 (-) villous epithelial cells do exhibit a 
significant rate of pHi recovery (H+ efflux).  *Significantly different from WT.   
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Cl-out/HCO3-in exchange (i.e., HCO3- influx) during Cl- removal is increased in the 
presence of Gly-Sar as compared to control (Fig. 4.5A).  In contrast, the mean rate of Cl-
in/HCO3-out exchange (i.e., HCO3- efflux) during Cl- replacement is unaffected (Fig. 4.5B).  
The increased rate of HCO3- influx in the presence of Gly-Sar is consistent with the 
activity of a HCO3- importing process that predominates in the upper villous epithelium 
during peptide absorption.  However, these results must be discerned from a simple pH 
gradient favorable for dipeptide absorption.  Previous studies have demonstrated that 
dipeptide uptake across the intestinal apical membrane is enhanced by an inwardly-
directed pH gradient (111); therefore, an enhanced rate of HCO3- influx would help 
support this gradient (50).  However, if the maintenance of this gradient is responsible for 
the enhanced rate of Cl-out/HCO3- exchange in the presence of Gly-Sar, a parallel decrease 
in Cl-in/HCO3-out exchange would be expected.  When bilateral methazolamide (100 µM) 
is applied to inhibit carbonic anhydrase activity, the increased rate of HCO3- influx in the 
presence of Gly-Sar is abolished, which supports the presence of a functional interaction 
between carbonic anhydrase and apical Cl-/HCO3- exchange (Fig. 4.5A and B).  Finally, 
to examine whether PAT-1 activity is specifically required for this process, the rates of 
Cl-/HCO3- exchange during Gly-Sar exposure were compared between PAT-1 (-) and WT 
mice.  As shown in Fig. 4.5C and D, there is no significant difference in the rates of 
HCO3- influx and efflux in the PAT-1 (-) upper villous epithelium in the presence or 
absence of Gly-Sar revealing a dependence on PAT-1 activity for increased rate of Cl-out 
/HCO3-in during luminal peptide uptake.  
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Figure 4.5.  Comparison of Cl-/HCO3- exchange activity in duodenal villous epithelium 
of WT and PAT-1 (-) mice during luminal Gly-Sar absorption.  A - D.  Intact duodenum 
was superfused in the luminal bath for 20 minutes with 20 mM Gly-Sar with or without 
100 µM methazolamide prior to luminal Cl- removal and replacement.  A and B.  In WT 
duodenal epithelium, the rate of HCO3- influx (mean ± SE) (A) was increased in the 
presence of luminal Gly-Sar (n = 5), but not with luminal Gly-Sar with methazolamide (n 
= 3) compared to the control (n = 6), whereas the rate of HCO3- efflux (B) during Cl- 
replacement was unaffected.  a,b,c, Means with the same letters are not statistically 
different.  C and D.  In PAT-1 (-) duodenal villous epithelium, HCO3- influx (C) and 
HCO3- efflux (D) rates during luminal Cl- removal and replacement were not significantly 
different in the presence or absence of Gly-Sar (n = 3).  *Significantly different from 
WT. 
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Discussion 
 Uptake of peptides via the small intestinal transporter PEPT1 is driven by an 
inward H+ electrochemical gradient that is established by the acid microclimate of the 
lumen (67).  The maintenance of the transepithelial pH gradient during nutrient 
absorption is critical for efficient absorption.  Based upon studies in intestinal cell lines 
and intact villous epithelium, the driving force for absorption is sustained in part by H+ 
efflux via apical membrane NHE activity (50;94;112;113).  However, the role of other 
acid-base transporters, including apical membrane Cl-/HCO3- exchangers and carbonic 
anhydrases, in pHi regulation during peptide absorption has not been fully evaluated.  
Therefore, we investigated pHi regulation during absorption of the PEPT1 dipeptide 
substrate Gly-Sar across the villous epithelia of intact intestinal mucosa from CAII (-) 
and PAT-1 (-) and WT mice to determine the nature of pHi regulation under physiologic 
conditions.   
 In the present investigation, Isc studies indexing transepithelial absorption of Gly-
Sar in the murine duodena revealed that substantial Gly-Sar absorption occurs under 
physiologic conditions.  With application of EIPA to inhibit apical membrane NHE 
activity, the absorption was reduced by approximately 60% indicating that the chemical 
driving force for peptide absorption can be maintained by additional acid-base 
transporters.  In addition, measurement of acidification rates during Gly-Sar absorption 
during inhibition of apical membrane NHE activity in the presence of CO2/HCO3- 
showed that villous epithelial cells are able to maintain pHi, demonstrating the apparent 
involvement of a HCO3--dependent process. 
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 Previous studies implicate the participation of carbonic anhydrase in facilitating 
the diffusion of H+ away from the subapical space after entry into enterocytes (103).  
However, the identity of the participating carbonic anhydrase isozyme(s) has yet to be 
resolved.  In the present investigation, we initially measured changes in pHi induced by 
peptide absorption during carbonic anhydrase inhibition with methazolamide (a broad 
spectrum inhibitor) in intact duodenal mucosa.  These studies revealed a significantly 
increased rate of acidification in the methazolamide-treated villous epithelial cells as 
compared to control.  We advanced these studies by utilizing intestine from mice 
deficient of CAII, the most widely expressed isozyme of the small intestine.  
Phenotypically, the CAII (-) mouse has been associated with growth retardation as well 
as renal acidification supporting its involvement in the regulation of pHi during peptide 
absorption (98).  Measurement of H+ influx during Gly-Sar absorption in the CAII (-) 
intestine demonstrated a significantly increased rate of acidification compared to the WT, 
which was similar in magnitude to the rate observed with the methazolamide-treated 
intestine.  Thus, these findings indicated that CAII is the principal carbonic anhydrase 
isozyme involved in the maintenance of pHi during peptide absorption.   
 Carbonic anhydrase catalyzes the reversible hydration of CO2 to HCO3- and H+, a 
reaction limited by the relative concentrations of components in the CO2 buffer system 
(i.e., HCO3-, CO2, and H2CO3).  Since HCO3- is reasonably cell-impermeant, we 
hypothesized that a Cl-/HCO3- exchanger may contribute to the import of HCO3- across 
the apical membrane that could neutralize H+ entering via PEPT1.  In addition, several 
lines of evidence have demonstrated associations between cytosolic CAII and apical Cl-
/HCO3- exchange proteins, which includes members of the Slc26a family (DRA and 
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PAT-1) and the Slc4 family (AE4) (4;68;100-102).  Initial pHi measurements were 
performed during inhibition of apical membrane Cl-/HCO3- exchange by the removal of 
bilateral Cl- or treatment with NFA.  These studies indicated an impaired ability of the 
duodenal villous epithelia to regulate pHi in the presence of Gly-Sar during inhibition of 
Cl-/HCO3- exchange.  Ussing chamber studies also showed a significant reduction in Gly-
Sar absorption during inhibition of apical Cl-/HCO3- exchange with NFA.  Together, 
these studies demonstrate that functional Cl-/HCO3- exchange in the apical membrane is 
required for optimal absorption of dipeptides across the intestinal epithelium under 
physiologic conditions.  Based on evidence that PAT-1 is the principal apical Cl-/HCO3- 
exchanger of the upper duodenal villus (Chapter 3) where PEPT1 is expressed at highest 
levels, we examined the specific role of PAT-1 in regulating pHi during peptide 
absorption.  These investigations revealed a significantly reduced pHi and an increased 
rate of H+ influx in the PAT-1 (-) upper villus during Gly-Sar transport as compared to 
WT.  The rate of acidification observed in the PAT-1 (-) epithelium is comparable to the 
rate observed during inhibition of Cl-/HCO3- exchange with bilateral Cl- free conditions 
indicating that PAT-1 is the principal Cl-/HCO3- exchanger involved in the regulation of 
pHi during peptide absorption.  It is interesting to note that PAT-1 (-) mice do not 
demonstrate growth retardation (119).  However, these observations were made during 
the provision of a well-balanced diet fed ad libitum.  Therefore, growth rates should be 
measured in PAT-1 (-) and WT mice during challenge with a restricted protein diet.  In 
contrast to the PAT-1 (-) mouse, the DRA (-) mouse, which is a model for human 
congenital chloride-losing diarrhea, does exhibit significant growth retardation, which 
previously has been attributed to a persistent secretory diarrhea and a resultant failure to 
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thrive (17;51;71);  however, the involvement of DRA in nutrient absorption has not been 
investigated.  Furthermore, DRA does demonstrate a significant contribution (30-40%) to 
apical Cl-/HCO3- exchange in the murine upper duodenal villus.  Therefore, studies of 
DRA (-) mice also are warranted to investigate the contribution of DRA to PEPT1-
mediated absorption. 
 Previous studies in cell lines transfected with PAT-1 have demonstrated that 
inhibition of endogenous CAII reduces the anion exchange activity of PAT-1 (4).  In 
addition, analysis of amino acid sequences of the carboxy-terminus of PAT-1 has 
revealed the presence of a CAII binding motif (4).  This evidence suggests an interaction 
between PAT-1 and intracellular carbonic anhydrase, i.e., the “HCO3- transport 
metabolon” (68) that facilitates HCO3- influx to protect the epithelial cell against 
intracellular acidification.  However, relatively little is known regarding the relationship 
of PAT-1 with CAII in native intestinal epithelia.  In murine duodenal villi, there is an 
indication that PAT-1 may function as a base importer (i.e., Cl-out/HCO3-in exchange) as 
based on the specific condition of studies in PAT-1 (-) intestine (Chapter 3).  Therefore, 
we hypothesized a novel derivation to the HCO3- metabolon whereby PAT-1 and CAII 
mediate HCO3- uptake during H+/peptide transport to minimize intracellular acidification 
and sustain peptide absorption (Figure 4.6).  To test this hypothesis, we measured the rate 
of apical membrane Cl-/HCO3- exchange in murine duodenal villous epithelia in the 
presence of Gly-Sar.  These studies indicated that the rate of Cl-out/HCO3-in exchange was 
significantly increased in the presence of Gly-Sar as compared to control, whereas, there 
was no change in the rate of Cl-in/HCO3-out exchange.  These results support the 
possibility that activity of an apical membrane Cl-/HCO3- exchanger facilitates HCO3- 
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Figure 4.6.  Cell model depicting the proposed activity of PAT-1 and CAII in the 
presence of peptide absorption.   
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import during peptide absorption.  Since PAT-1 is the major Cl-/HCO3- exchanger of 
upper duodenal villous epithelia, we expanded these studies to evaluate Cl-/HCO3-
exchange in the PAT-1 (-) villous epithelia during apical Gly-Sar exposure.  In the PAT-1 
(-) epithelium, enhancement of Cl-out/HCO3-in exchange was abolished, suggesting that Cl-
/HCO3- exchange activity of PAT-1 is exclusively involved in the HCO3- import process.  
Finally, to evaluate the interaction between carbonic anhydrase and apical Cl-/HCO3- 
exchange activity, bilateral methazolamide was applied to murine duodena in the 
presence of Gly-Sar.  This maneuver also reduced Cl-out/HCO3-in exchange to the level of 
the control, supporting the existence of a functional coupling between PAT-1 and 
carbonic anhydrase during PEPT1 transport. 
In conclusion, our studies indicate that optimal dipeptide absorption through 
PEPT1 in the murine duodena depends not only on the activity of apical membrane 
Na+/H+ exchange, but also on the coordinated activities of HCO3--dependent acid-base 
transporters.  Examination of CAII and PAT-1 (-) mice indicate that both PAT-1 and 
CAII contribute to pHi regulation during peptide absorption.  PAT-1 was found to 
principally function in Cl-out /HCO3-in exchange during the presence of Gly-Sar in 
duodenal villous epithelia, thus allowing for transmembrane movement of membrane-
impermeant HCO3-   By forming a HCO3- transport metabolon with CAII, this mode of 
transport by PAT-1 could effectively buffer the intracellular H+ influx that occurs during 
peptide absorption.   
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Chapter 5 
CONCLUSIONS AND FUTURE STUDIES 
 
 
CFTR Facilitation of Basal Cl-/HCO3- Exchange in the Villous Epithelium of Intact 
Murine Duodenum 
Summary and Conclusions 
 Basal HCO3- secretion by the duodenum is largely mediated by the activity of 
anion exchangers and reduced rates of secretion have been reported for CF patients and 
CF mouse models (84).  Investigation of the basal activity of anion exchange across the 
apical membrane of epithelial cells in the upper to mid-region of villi of intact duodenal 
mucosa from wild-type (WT) and PAT-1(-), DRA(-), and AE4(-) mice indicates that 
PAT-1 is the principal Cl-/HCO3- exchanger in the apical membrane of the upper villous 
epithelium with a smaller but significant contribution by DRA (30-40%), and minimal 
contribution from AE4 (<5%) (Chapter 3).  Examination of Cl-/HCO3- exchange in the 
CF mouse intestine suggests that CFTR facilitates this anion exchange activity by 
providing a Cl- ‘leak’ channel that enables sustained Cl-in/HCO3-out exchange activity 
under basal (non-stimulated) conditions (Figure 5.1A) based upon the evidence that 1) 
CFTR(-) intestine has lower rates of villous Cl-/HCO3- exchange as compared to WT and 
2) WT anion exchange is reduced to the level measured in the CF duodenum when either 
a CFTR-impermeant anion (SO42-) is used for exchange or CFTR channel activity is 
blocked with glybenclamide (Chapter 2).  However, recent studies show that the CFTR 
blocker glybenclamide may also inhibit human DRA (58).  Further, as shown in our
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Figure 5.1.  Two proposed models for reduced Cl-/HCO3- exchange in the CFTR (-) 
upper duodenal villus.  One model (A) supports indirect facilitation of Cl-/HCO3- 
exchange by CFTR.  The second model (B) suggests that DRA is inactive in the CF 
upper villus.
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subsequent studies (Chapter 3), murine DRA does not participate in SO42-/HCO3- 
exchange, thus indicating a caveat to our conclusion based on the requirement for CFTR-
permeant anions.  In addition, ~30% of Cl-/HCO3- exchange in the upper villus was found 
to be due to DRA activity, which is almost equivalent to the reduction in Cl-/HCO3- 
exchange seen in the CF mouse intestine (Chapter 3).  Therefore, these findings raise the 
alternative hypothesis that the reduction in Cl-/HCO3- exchange in the CF upper villus is 
due to decreased activity of DRA and not CFTR Cl- conductance (Figure 5.1B).   
Supplemental Studies 
 To investigate the possibility that DRA expression is reduced or that DRA is 
inactive in CF duodenal villus, we first examined the ability of glybenclamide to inhibit 
DRA activity in the murine cecum where DRA is the predominant apical Cl-/HCO3- 
exchanger (Figure 5.2, left panel).  These studies revealed that glybenclamide had very 
little effect on the rate of Cl-/HCO3- exchange activity in the murine cecum where DRA 
activity is "isolated" (Figure 5.2, right panel).  Next "isolated" DRA was examined in the 
presence and absence of CFTR activity by comparing Cl-/HCO3- exchange rates between 
PAT-1 (-)/CFTR (+) and PAT-1 (-)/CFTR (-) double knockout mice in the upper 
duodenal villus (Figure 5.3).  These studies revealed no significant difference in the rate 
of Cl-/HCO3- exchange in the presence or absence of CFTR indicating that DRA is indeed 
active in the murine CF intestine, adding further credence to the Model A (Figure 5.1) 
that CFTR recycles Cl- back to the extracellular milieu to provide a favorable Cl- 
concentration gradient for exchange activity.  We have, however, demonstrated a trend 
towards reduced DRA mRNA expression in the CFTR (-) duodenum (Chapter 2); 
therefore, it is still necessary to measure the level of DRA expression in the upper villous
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Figure 5.2.  The effect of glybenclamide on DRA Cl-/HCO3- exchange activity.  (Right) 
Cl-/HCO3- exchange activity in the cecal surface epithelium of DRA (-) and WT (n = 5) 
mice.  * Significantly different from WT.  (Left) Cl-/HCO3 exchange in the murine cecum 
in the presence and absence of glybenclamide (n = 3).   
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Figure 5.3.  Isolation of DRA activity in the presence and absence of CFTR.  Cl-/HCO3- 
exchange in the upper duodenal villus from PAT (-) (n = 5) and PAT (-)/CFTR (-)          
(n = 2). 
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epithelium of CF and WT mice, and this will be determined through the use of laser 
capture dissection and quantitative RT-PCR.  Finally, the ability of CFTR to specifically 
facilitate PAT-1 exchange will be investigated.  For these studies, the DRA (-) intestine 
will be used to isolate PAT-1, which will allow us to compare the rates of anionin/HCO3-
out exchange between CFTR-permeant anions (Cl-, NO3-) and the CFTR-impermeant 
anion SO42- in the luminal bath.  Increased PAT-1 activity during Cl-/HCO3- or NO3-
/HCO3- exchange as compared to SO42-/HCO3- exchange would support the hypothesis 
that CFTR specifically facilitates PAT-1 activity by providing a Cl- leak pathway.  
 
Identification of the Apical Membrane Anion Exchanger(s) Responsible for Basal 
Bicarbonate Secretion 
Summary and Conclusions 
Loss of CFTR facilitation of basal Cl-/HCO3- exchange by PAT-1 in the upper villous 
epithelium of the duodenum may represent only one component of reduced basal HCO3- 
secretion in the CF intestine.  Recent pH stat studies of PAT-1 (-) murine duodenum 
estimate that PAT-1 contributes only 20% to basal HCO3- secretion in WT duodenum 
(Figure 5.4, left panel).  Because our examination of basal anion exchange was restricted 
to the upper villus, it appears that the majority of duodenal HCO3- secretion under basal 
conditions comes from the lower villous and crypt epithelium where that activities of 
DRA or AE4 may provide a major contribution to basal HCO3- secretion.  Therefore, a 
thorough examination of Cl-/HCO3- exchange in the lower villus/crypt epithelium where 
CFTR is predominantly expressed is warranted in order to fully evaluate the contributions 
of AE4, DRA, and PAT-1 to transepithelial bicarbonate secretion.
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Figure 5.4.  Transepithelial HCO3- secretion across duodena from PAT-1 (-) (left panel,       
n = 3) and DRA (-) (right panel, n = 8 - 10) and WT mice as measured by pH stat.  
*Significantly different from WT. 
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Supplemental Studies 
 Initial studies indicate that DRA is responsible for ~80% of basal HCO3- secretion 
across the murine duodenum (Figure 5.4, right panel).  Further, in situ hybridization 
studies of rabbit duodenum have shown greatest mRNA expression of DRA in the lower 
villous and crypt epithelia (48).  These findings indicate significant DRA activity in the 
duodenum; therefore, we investigated the possibility that DRA function is primarily 
localized to the lower villus (near crypt openings) by comparing rates of apical 
membrane Cl-/HCO3- exchange activity in the duodena of mice with gene-targeted 
deletions of DRA, PAT-1 and AE4.  Examination of Cl-/HCO3- exchange in the lower 
duodenal villus revealed no significant difference in the rates of HCO3- influx and efflux 
during Cl- removal and replacement as compared to the upper villus (Figure 5.5).  
Comparison of the rates of apical membrane Cl-/HCO3- exchange activity in the lower 
duodenal villus of mice with gene-targeted deletions of DRA, PAT-1 and AE4 reveal that 
PAT-1 and AE4 do not significantly contribute to Cl-/HCO3- exchange in lower villous 
epithelium (Figure 5.6).  In distinct contrast to the upper villus, Cl-/HCO3- exchange 
activity is eliminated in the lower villous epithelium of the DRA (-) intestine (Figure 5.7).  
In addition, it is interesting to note that epithelial cells from the DRA (-) lower villus 
paradoxically acidify upon luminal Cl- removal and alkalize after Cl- replacement (Figure 
5.7 and 5.8).  It is known that CFTR conducts HCO3- in addition to Cl-, but its 
permeability is significantly less (1:4) (80;105). In addition, recent research has shown 
that recombinant CFTR HCO3- permeability may be regulated by the Cl- content of the 
extracellular medium (89).  Therefore, to investigate whether this observation is due to 
changes in the HCO3- permeability of CFTR during removal of luminal Cl-, Cl/HCO3-
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Figure 5.5.  Rates of HCO3- influx and efflux in upper and lower villous epithelia of WT 
duodenum (n = 5 - 9). 
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Figure 5.6.  HCO3- influx and efflux of PAT-1 (-) and WT (upper panel, n = 5) and  
AE4 (-) and WT (lower panel, n = 3 - 4) lower villous epithelium.  In contrast to upper 
villous epithelium, loss of PAT-1 has no effect on the rate of Cl-/HCO3- exchange, while 
loss of AE4 results in a small (~25%) reduction in HCO3- influx but no change in HCO3- 
efflux.  *Significantly different than WT. 
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Figure 5.7.  Rates of Cl-/HCO3- exchange in WT, DRA (-), and DRA (-)/CFTR (-) 
duodenal lower villous epithelia (n = 3).  Intracellular acidification during Cl- removal in 
the DRA (-) was eliminated in the DRA (-)/CFTR (-). a,b,cMeans with the same letter are 
not statistically different.  
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Figure 5.8.  Changes in pHi during luminal Cl- removal and replacement in A. WT,       
B. DRA (-), and C. DRA (-)/CFTR (-) lower villous epithelia.  The pHi was unchanged in 
DRA (-)/CFTR (-) epithelium during Cl- removal and replacement.  To ensure viability of 
these preparations, apical Na+/H+ activity was assessed by Na+ removal and replacement 
in the absence of bath HCO3-.  
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exchange activity was examined further in the lower villus by utilizing DRA (-)/CFTR (-) 
mice.  Preliminary studies revealed that this paradoxical acidification is eliminated in the 
DRA (-)/CFTR (-) duodenum (Figure 5.7 and 5.8).  Taken together, these findings 
indicate that 1) basal HCO3- secretion is primarily mediated by DRA (~80%) and PAT-1 
(~20%) Cl-/HCO3- exchange activity, 2) unlike the upper villous epithelium where PAT-1 
activity predominates, DRA is the dominant Cl-/HCO3- exchanger in the lower villous 
epithelium, 3) DRA exists in a complex interaction with CFTR in the lower villous 
epithelium, and 4) in the absence of DRA activity, removal of luminal Cl- induces a 
paradoxical intracellular acidification by a process dependent on CFTR supporting the 
hypothesis that the HCO3- permeability of CFTR is increased in the absence of luminal 
Cl-.  Additional studies are needed to evaluate the nature of the interaction that exists 
between DRA and CFTR.  Initial studies reveal that, similar to the upper villus, the lower 
villus of the CF mouse duodenum has an increased pHi and significantly reduced rates of 
Cl-/HCO3- exchange activity (Figure 5.9).  Therefore, studies are planned to evaluate 
whether the interaction of DRA with CFTR in the lower villus is due to a facilitation of 
Cl-/HCO3- exchange by CFTR or due to direct intermolecular interactions between the 
two proteins.  Reagents blocking CFTR channel activity will test whether the activity of 
CFTR is required to support DRA Cl-/HCO3- exchange.  On the other hand, if the above 
studies indicate that the membrane presence of CFTR is required but not its Cl- channel 
activity, then these results suggest an intermolecular interaction between CFTR and 
DRA. 
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Figure 5.9.  Summary of A. baseline pHi, B. HCO3- influx, and C. HCO3- efflux rates in 
lower villous epithelial cells from WT (n = 5) and CF (n = 4) mice.  *Significantly 
different from WT.
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The Role of PAT-1 in Intestinal Peptide Absorption 
Summary and Conclusions 
 The upper villous epithelium of the duodenum is exposed to acid challenge not 
only from gastric effluent, but also from H+ influx via the H+ di-/tripeptide cotransporter 
PEPT1 (expressed predominantly in the upper villous epithelium) (28).  Studies in the 
PAT-1 null duodenum indicate that PAT-1 is responsible for approximately 80% of 
villous apical Cl-/HCO3- exchange activity (Chapter 3).  In addition, pHi measurements 
under conditions that isolate apical membrane acid-base transport in the PAT-1 (-) villous 
epithelium in the presence of CO2/HCO3- have revealed a significantly reduced baseline 
pHi as compared to WT suggesting that PAT-1 protects against epithelial cell 
acidification, ostensibly by running in Cl-out/HCO3-in mode that is HCO3--dependent 
(Chapter 3).  Studies presented in Chapter 4 have indicated that PAT-1 is involved in pHi 
regulation during dipeptide absorption.  The activity of PAT-1 as a base importer (Cl-
out/HCO3-in exchange) would allow for transmembrane movement of membrane-
impermeant HCO3- needed to combine with protons absorbed during transport of peptides 
through PEPT1 for the maintenance of pHi.  An initial study demonstrated an enhanced 
rate of Cl-out/HCO3-in exchange via PAT-1 in the presence of the dipeptide Gly-Sar, 
providing support to this hypothesis (Chapter 4).  Further studies revealed the 
involvement of carbonic anhydrase, specifically CAII, in peptide absorption and a 
reduction in the rate of Cl-out/HCO3-in exchange in the presence of Gly-Sar to the level of 
the control during inhibition of carbonic anhydrase activity, endorsing the existence of a 
functional coupling between PAT-1 and carbonic anhydrase during PEPT1 transport.  
Taken together, these data indicate the existence of a HCO3- metabolon whereby PAT-1 
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and CAII mediate HCO3- uptake during H+/peptide transport to minimize intracellular 
acidification and sustain peptide absorption.   
Future Studies 
 The preceding section and Chapter 4 have demonstrated the involvement of PAT-
1 and CAII in peptide absorption.  These studies have laid the groundwork for additional 
studies to expand our knowledge of the interaction between PAT-1 and CAII and the 
mode of activity of PAT-1 during peptide absorption.   
 To conclusively demonstrate whether PAT-1 functions in Cl-out/HCO3-in exchange 
during dipeptide absorption, measurements of intracellular Cl- [Cl-]i during Gly-Sar 
absorption are planned with the use of the fluorescent dye 6-methoxy-N-ethyl-1,2-
dihydroquinoline (diH-MEQ).  A decrease in [Cl-]i during Gly-Sar exposure would 
provide definitive evidence that PAT-1 is acting as a HCO3- importer during peptide 
absorption via PEPT1.  Currently, there is little data regarding use of [Cl-]i indicators in 
intact tissue.  Therefore, extensive development of this technique will be required prior to 
experimentation to determine 1) the appropriate loading dose, 2) assessment of 
background fluorescence, photobleaching, and dye leakage, and 3) a calibration protocol 
for converting fluorescence to [Cl-]i.  In addition, interpretation of intracellular Cl- 
measurements during peptide absorption may be complicated by basolateral Cl- uptake 
through the Na+K+2Cl- cotransporter (NKCC1) and the Cl-/HCO3 exchanger AE2.  
Therefore, it may be necessary to perform these studies under conditions that inhibit 
basolateral Cl- uptake (i.e., bumetinide-treated or basolateral Cl- free).   
 Initial studies in murine duodenal villous epithelia have demonstrated the 
presence of a functional interaction between PAT-1 and carbonic anhydrase (Chapter 4).  
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However additional studies are planned to determine whether a direct interaction between 
PAT-1 and CAII exists as well.  Previous investigations in heterologous cell systems 
have co-localized PAT-1 and CAII to the plasma membrane, and a binding motif for 
CAII has been identified on the carboxy-terminus of the PAT-1 (4).  In addition, 
phosphorylation by protein kinase C (PKC) of the adjacent residue on PAT-1 has been 
shown to decrease the interaction between PAT-1 and CAII (4).  The ability of PAT-1 to 
directly bind with CAII will be evaluated in murine isolated duodenal villi by means of 
co-immunoprecipitation studies.  In these studies, PAT-1 and CAII will be separately 
immunoprecipitated from the isolated villi and probed with CAII and PAT-1 antibodies, 
respectively, to determine whether a direct intermolecular association exists between 
PAT-1 and CAII.   
 Although our findings demonstrate the importance of PAT-1 in pHi regulation 
during PEPT1 absorption, initial studies have demonstrated that inhibition of apical 
membrane Cl-/HCO3- exchange with NFA results in a ~70% reduction in Gly-Sar uptake 
as indexed by Isc current, which was surprising as NFA only inhibits ~60% of Cl-/HCO3- 
exchange (Chapter 2 and 4).  Therefore, additional studies are planned to directly 
examine Gly-Sar absorption by Isc in PAT-1 (-) duodena as compared to WT.  PEPT1 
expression studies in isolated duodenal villi also are necessary to determine whether a 
decreased level of PEPT1 expression as measured by quantative RT-PCR in isolated 
murine duodenal villi may be contributing to the impaired pHi regulation in the PAT-1 (-) 
epithelium during peptide absorption.  Further, the involvement of DRA in nutrient 
absorption has not been investigated.  DRA demonstrates a significant contribution (30-
40%) to apical Cl-/HCO3- exchange in the upper duodenal villus and ~100% in the lower 
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duodenal villus of the mouse.  Therefore, studies of DRA (-) mice assessing Isc and pHi 
regulation are warranted to investigate the contribution of DRA to PEPT1-mediated 
absorption.   
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APPENDIX 1 
pHi MEASUREMENT IN INTACT INTESTINAL TISSUE 
 
 
Setup of Perfusion Lines for Microfluorimetry Studies 
1.  To set up the perfusion lines, you need: 
 Six male 1/16 in. barbed luers 
 Two female 1/16 in. barbed luers 
 Two glass capillary tubes (15 cm in length; O.D. 1.5 mm; I.D. 1.17 mm) 
 Two pieces of silastic tubing (20 cm in length; I.D. 0.078 in.; O.D. 0.125 in.) 
 Two pieces of yellow/blue collared PVC tubing (18 in.in length; O.D. 1.52 mm) 
 Two blunt tip needles with luer hubs (20 gauge; ½ in. in length) 
 Two blunt tip needles with luer hubs (18 gauge; ½ in. in length) 
 Two pieces of PE160 tubing (95 cm in length; O.D. 1.57 mm; I.D. 1.14) 
 Four pieces of Tygon tubing (4 cm in length; O.D. 1/8 in.; I.D. 1/16 in.) 
 Two 3 mL syringes 
 
2.  Attach a glass capillary tube to a piece of silastic tubing.  The capillary tube is placed 
directly in the warmed Ringer's solution to draw up the solution during the experimental 
protocol. 
3.  Attach a piece of the silastic tubing to a male barbed luer. 
4.  Attach the male barbed luer to a female barbed luer which is attached to a piece of 
yellow/blue collared PVC tubing in the end closest to the blue collar.  Fit the PVC tubing 
to a Dynamax peristaltic pump by releasing the compression arm.  This is accomplished 
by pressing the beveled trigger key toward the rollers.  Then insert the blue collar into 
one of the left grooves on the collar bracket.  Thread the tubing around the rollers so that 
the yellow collar fits into the groove on the opposite collar bracket.  Then close the 
compression arm on the tubing and close the locking arm.  Attach a male barbed luer to 
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the end of the PVC tubing closest to the yellow collar.  The peristaltic pump should be set 
to a flow rate of 24.2 rpm. 
5.  Attach the male barbed luer from the PVC tubing to a 20 gauge blunt tip needle.  
Remove the plunger from a 3 mL syringe.  Remove the rubber stopper from the end of 
the plunger.  Insert the blunt tip needle through the center of the rubber stopper.  Position 
the rubber stopper into the barrel of the syringe so that it forms a seal. 
6.  Insert the tip of an 18 gauge blunt tip needle into a piece of PE160 tubing and attach 
this to the syringe tip. Introduce the PE160 tubing through the opening on the side of the 
microscope cage. 
7.  Attach a piece of Tygon tubing to the distal end of the in-line heater and insert the end 
of the PE160 tubing into the end of the Tygon tubing. 
8.  Attach a piece of Tygon tubing to the proximal end of the inline heater and attach a 
male barbed luer into the end.  During the experiment, the male barbed luer will be 
attached to the horizontal Ussing chamber. 
9.  Repeat steps 2-8 to set up both the apical and basolateral perfusion lines. 
10.  The basolateral perfusion line will be the lower perfusion line in the peristaltic pump, 
and the apical perfusion line will be the upper line.  PE160 tubing of the basolateral line 
should be labeled with green tape and should be run through the in-line heater that is 
labeled with green tape.  The basolateral line will be attached into the bottom perfusion 
inlet of the Ussing chamber and the apical line will be attached to the top perfusion inlet 
of the Ussing chamber. 
11.  The perfusion lines should be changed once a week (or if switching drugs). 
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Setting up for a BCECF Microfluorimetry Study 
1. Warm Ringers solutions in a 40 ºC water bath for at least 1 hour.  In general, 250 ml 
of basolateral and 100 mL of apical solution are required per experiment. Gas HCO3--
buffered Ringer’s (i.e., KBR and IBR) with 95% O2 /5% CO2; and HCO3--free Ringers 
(i.e., TBR) with 100% O2 while warming.   
2. Turn on the space heater underneath the microscope station and the warmer within 
the microscope cage, which should be set to 35 ºC.  Turn on solution in-line heater 
temperature probes to monitor the air temperature in the microscope cage.  Close the 
sliding door on the microscope cage and allow the station to be heated for ~1 hour. 
3.  While everything is warming, add TTX (0.1 µM) and INDO (1.0 µM) and any other 
necessary drugs to the basolateral solution(s).  Add INDO (1.0 µM) and any other 
necessary drugs to the apical solution(s). 
4.  Turn on the vacuum for the perfusion chamber.  Check the beaker where fluid is 
collected to determine whether the beaker needs to be emptied prior to the experiment. 
5.  Turn on the xenon lamp.  Turn on the silver filter wheel control box.  Turn on the 
computer.  Let the computer boot up completely.  Turn on the camera. 
6.  Open axon imaging program.  Go to Hardware--illumination settings.  A window 
titled Ludl Filter Wheel should open.  Turn the cube housing until the green tape is in 
front, which places the 535 nm emission filter into the field of view.  Open the shutter 
{O: icon in the toolbar on the left of the screen).  The Ludl Filter wheel window has a 
graphical representation of a filter wheel with the places for the filters numbered.  The 
440 nm wavelength is royal purple and should be positioned in optical port 1, and the 495 
nm wavelength is teal and should be positioned in optical port 2.  Check to make sure the 
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filters are in the appropriate location and position the filter wheel so that optical port 2 
(495 nm filter) is placed in the field of view.  Close the shutter and the Ludl Filter Wheel 
window. 
7.  Click on the third icon on the toolbar on the left side of the screen to set the computer 
to save all images (changes icon from red to green). 
8.  Change the file name on the acquisition.  Go to Settings--Acquisition--the tab labeled 
General--and click Change.  Name the file based upon the mouse's individual 
identification code and note the file name on the experimental record. 
9.  Put a 12x18 mm piece of bottom mesh (136 micron nylon mesh) on the chamber and 
secure over the pins.  Replace the tubing on the bottom perfusion inlet (27 mm of PE160 
tubing).  If the tubing on the top perfusion inlet needs to be changed, use 17 mm of 
PE160 tubing.  Both the top and bottom perfusion inlets use 18 gauge blunt tip needles.  
Cut a 20x60 mm piece of upper mesh (flexible nylon mesh with 1 mm openings). 
10.  Prime basolateral perfusion line.  This is accomplished by placing the glass capillary 
tube of basolateral perfusion line into basolateral solution and turning on peristaltic pump 
to allow clockwise flow of fluid.  Disconnect the syringe of the basolateral perfusion line 
from the PE160 tubing so that the syringe can be filled with ~1.5 mL of reserve fluid.  
Reattach the PE160 tubing and partially fill this tubing with fluid.  Stop the peristaltic 
pump.  
 
Starting a BCECF Microfluorimetry Experiment 
1.  Set up an ice-cooled dissection bath using KBR with 1 µM indomethacin (10 µL from 
the concentrated stock in 100 ml of KBR).  Sacrifice mouse.  Remove duodenum via an 
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abdominal incision.  Under the dissection microscope, open along the mesenteric border.  
Incubate in the dissection bath for 10 minutes. 
2.  While using a dissection microscope, pin tissue flat with the mucosal side down on a 
Sylgard-filled Petri dish.  Score the tissue along the proximal end of the tissue with a #11 
scalpel blade.  Remove the serosa and muscularis externa along the longitudinal axis by 
blunt dissection using fine forceps.   
3.  For upper villous pHi measurements, mount muscle-stripped intestinal preparations 
mucosal side up on a horizontal Ussing chamber with the pyloric end nearest the 
perfusion inlet (Figure A1.1).  Put vacuum grease around the periphery of the chamber 
bottom so that it encircles the tissue.  This can be accomplished by using a 10 mL syringe 
that has been filled with vacuum grease.  Place top mesh over tissue.  For lower villus 
measurements, a short piece of glass capillary tubing (1.2 mm O.D) is placed 
longitudinally beneath the mucosa on the supporting mesh.  The mucosa is held against 
the tubing by two longitudinally oriented silk threads, thereby throwing the mucosa into 
relief.  The overlying loose mesh is then sandwiched over the preparation to immobilize 
the tips of the villi (Figure A1.2).  
4.  Place top of chamber on, pull slightly on the upper mesh to trap the tips of a small 
percentage (< 1%) of villi under strands of the mesh (for upper villus preparations), and 
tighten flathead screws (1 mm in length) slowly.   
5.  Place chamber on the stage of the fluorescent microscope.  Attach perfusion lines to 
perfusion inlets of chamber with the apical perfusion line attached to the top line of the 
chamber and the basolateral perfusion line attached to the bottom line of the chamber.   
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Figure A1.1.  Schematic of horizontal Ussing chamber. 
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Figure A1.2.  Schematic of duodenal preparation to visualize lower villous epithelium.  
A 2 cm length of 1.2 mm diameter glass capillary was placed on the serosal side of the 
mucosa which was secured to the capillary by two parallel threads 1 mm apart.   
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Attach chamber suction lines (16 gauge stainless steel suction tubes attached to 6 cm of 
silastic tubing that are fitted with 1/16 in. female barbed luers) to yellow vacuum tubing.   
Position the basolateral suction line in the basolateral suction reservoir of chamber (see 
Figure A1.1 and A1.3). 
6.  Start peristaltic pump.  Because only the basolateral perfusion line is primed it will 
only perfuse this surface.  Check to make sure there are no air bubbles in the basolateral 
opening of the chamber.  If there are bubbles present, tilt the chamber at a 45° angle to 
the stage and strike it against the stage to force the bubbles from the chamber opening. 
7.  Place 1 mL of DL-dithiothreitol (DTT) solution (100 µM final concentration: 5 µl of a 
20 mM stock is added to 1 mL of apical solution) on the apical surface of the tissue for 5 
minutes to remove overlying mucus. 
8.  After the 5 minute DTT incubation, remove the DTT solution from the top of the 
tissue by vacuum.   
9.  While the tissue is incubating with DTT, make up the BCECF-AM dye solution.  Each 
50 µg tube of dye is rehydrated in 10 µl of Methyl sulfoxide (anhydrous).  Add 2 µl of 
this stock to 1 ml of apical solution (16 µM final concentration) and vortex thoroughly to 
mix.  Add the dye solution to the top of the tissue and allow it to incubate for ~10 
minutes.   
9.  During BCECF incubation, place the chamber under the 40X water immersion 
objective.  Place the solution in-line heater probes into the chamber.  Turn on the bottom 
in-line heater.  Place the cube housing in position "o" (open circle) so that there are no 
filters in the field of view. Pull out the filter sliders, turn on the microscope light source 
to an intensity of ~4.5, and push the camera stop in (See Figure A1.4). 
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Figure A1.3.  Experimental setup for measurement of pHi in epithelial cells of intact 
duodenal villi.  
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Figure A1.4.  High power photograph of a setup for measurement of pHi in epithelial 
cells of intact duodenal villi.  
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Image Acquisition and Analysis  
1.  For pHi measurements of the upper duodenal villus, focus on an area in the mid-region 
of a single, immobilized villus (~ 1 mm from the villous tip) (see Figure A1.5).  For pHi 
measurements of the lower villus, the criterion for lower villous epithelium is 
visualization of crypt openings within the same microscopic field. 
2.  Pull out the camera stop.  Click the camera icon once on the axon imaging workbench.  
This should take a pseudo-colored picture (or a black and white depending on how the 
palette editor is set) of the villus.  If the picture is all white, there is too much light.  If the 
picture is all black (or purple to blue), there is too little light or the camera stop is not out.  
Adjust light or camera stop if necessary and retake the picture.  When a satisfactory 
picture is acquired, select approximately 10 epithelial cells for ratiometric analysis using 
a 40X water immersion objective.  Cover the bottom light with a black plastic strip.  Turn 
the cube housing to the 535 nm emission filter (labeled with green on the cube), pull out 
the filter sliders if they are not already out and make sure the camera stop is out.  Close 
the microscope cage to keep the tissue warmed.  Let the BCECF-AM dye load for 10 
minutes.  The amount of loading should be checked every few minutes to make sure the 
tissue is loading appropriately.  To assess dye loading, take fluorescent images for λ1 
(495 nm excitation).  Appropriate dye loading should be between 1000-2500 pixel values 
(which will appear on the screen as a color intensity ranging from light blue to green to 
yellow to orange).  If the tissue does not load within 10 minutes, a second dose of dye 
solution should be applied to the apical surface of the tissue. 
3.  When the tissue is finished loading, place the apical perfusion line in the appropriate 
solution and prime the line.  Place the top vacuum line in the apical vacuum reservoir.  
  
 
 
 
Figure A1.5.  Locale in the mid-region of a single villus for the measurement of 
epithelial cell pHi. 
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Turn on the top solution in-line heater.  Check to make sure top vacuum has started.  
Check to make sure the apical surface of the chamber is being perfused and that the fluid 
level is not fluctuating during suction.  Also, make sure the villus is still in focus, 
reposition if necessary, and reassess dye loading.  Close the microscope cage.   
4.  Start the acquisition.  Take 3 acquisitions in rapid succession and then place on a 
sample interval of 20 seconds with the use of the acquisition control pad.  Fluorescence 
intensity (FI) of the selected area is recorded at the 535 nm emission with a Sensi-Cam 
digital camera and processed with Axon Imaging Workbench.  Changes in intracellular 
pH (pHi) are measured by the dual excitation wavelength technique (440- and 495-nm).  
The intensity of emitted fluorescence at 495 nm stimulation is pH dependent, whereas 
that at 440 nm is not.  The ratio is determined by dividing the intensity at 495 nm by that 
at 440 nm after subtracting the average emission of the background intensity (BGI) at 
each wavelength.  The BGI is defined as the intensity of autofluorescence which was 
previously measured in villous epithelia from 6 mice in the absence of BCECF.  The 
fluorescence ratio is calculated by the equation: 
 Fluorescence ratio = (FI495 – BGI495)/ (FI440 – BGI440) 
Following the experiment, the resulting ratios are converted to pHi according to the 
calculated ex vivo calibration curve (see Section A2).   
5.  After a stable ratio is attained (will take at least 3 minutes), rates of acidification or 
alkalization are calculated from the initial slope of pHi changes during the first 80-100s 
after the experimental manipulation as ∆pHi/s, and the average pHi during this period is 
calculated. 
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6.  Convert ∆pHi/s to ∆pHi/min.  Calculate net flux rates by multiplying the total 
buffering (βtotal) of the system at the average pHi during anion exchange in ∆pHi/min (See 
Section A3). 
 
Cleaning up following Experiment: 
1.  Between experiments, throw away all mesh and clean the chamber to remove vacuum 
grease.  Rinse well with water.  Clean objective with a Q-tip and Sparkle glass cleaner.  
Drain the perfusion lines.  Check the fluid levels on all solutions prior to starting the next 
experiment. 
2.  Clean the scope station thoroughly at the end of the day (or if switching drugs). Rinse 
bubblers with water. 
3.  Weekly (or if switching drugs), throw away perfusion lines and clean in-line heaters 
by flushing with 20 ml of ethanol (70%) and 20 ml of DI water.   
4.  Once a week, soak the chamber in Alconox for 1 hour (or overnight).  Do not expose 
the chamber to ethanol.   
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APPENDIX 2 
CALIBRATION OF FLUORESCENT RATIO IN TERMS OF pHi 
 
 
Setting up for a pHi Calibration Experiment 
1.  Prepare 500 mL of High K+ pH buffers in 0.3 pH unit increments from 6.3 to 8.6.  
These solutions should not be gassed as they are prepared.  TES-buffered Ringers (TBR) 
and unbuffered Kreb's Ringer with TES (UK-TES) should be prepared for the initial 
perfusion of the tissue prior to the calibration experiment. 
2.  Make up a 4 mM stock of nigericin diluted in ethanol.  Nigericin, which is an H+/K+ 
antiporter, will cause rapid equilibration of the external and internal pH through an 
exchange of internal K+ for external H+. 
3.  Put pH solutions in a 40°C water bath to warm in 100 ml bottles.  Do not gas the pH 
buffer solutions.  Put the TBR and UK-TES into the water bath to warm also.  Gas TBR 
with 100% O2. 
4.  Turn on the dry bath and replace the pH meter calibration solutions.   
5.  Set up for a BCECF microfluorimetry study (see Section A.1).   
6.  While everything is warming, add 7.5 µl of the 4 mM nigericin stock to each 100 ml 
of pH buffer (30 µM final concentration).  Do not reuse solutions containing nigericin.  
TBR should contain TTX (0.1 µM) INDO (1.0 µM), and glucose (10 mM). The UK-TES 
needs INDO. 
7.  Calibrate the pH meter at 37°C. 
8.  Sacrifice mouse, mount tissue being calibrated mucosal side up (see Section A.1). 
 140
9.  Start the perfusion with TBR (serosal).  Put 1 mL of UK-TES on the mucosal side.  
Make up DTT in 1 ml of UK-TES (100 µM final concentration).  Remove the UK-TES 
from the top of the tissue by vacuum and replace with the DTT solution.  Incubate the 
tissue for 5 minutes with DTT. 
10.  While the tissue is incubating with DTT, make up the BCECF-AM dye solution. 
Each 50 µM tube of dye is rehydrated in 10 µl of Methyl sulfoxide.  Add 2 µl of the 
BCECF-AM stock and 1 µl of the 4 mM nigericin stock to 1 ml of the highest pH buffer. 
11.  After the 5 minute DTT incubation, apply the dye solution (note that nigericin will 
increase the efficiency of dye loading so the amount of loading should be checked after 5 
minutes and every 2 minutes thereafter to make sure you don't overload your tissue).    
 
Calibration of 495/440 Ratio in Terms of pHi 
1.  Place the chamber under the 40X water immersion objective.  Place the solution in-
line heater probes into the chamber.  Turn on the bottom in-line heater.  Place the cube 
housing in position "o" (open circle) so that there are no filters in the field of view. Pull 
out the filter sliders, turn on the microscope light source to an intensity of ~4.5, and push 
the camera stop in and follow the steps outlined in Section A1 under “Image Acquisition 
and Analysis.” 
2.  When the tissue is finished loading, place both perfusion lines in the highest pH buffer 
solution.  Start the top vacuum line.  Turn on the solution in-line heaters.  Put the pH 
electrode in the chamber in the top portion as close to the tissue as possible.  Start the 
acquisition.  Enter a comment indicating the pH the first buffer was titrated to.  Write 
down the pH of the first buffer in the treatment column of the experiment sheet. 
3.  Allow the ratio to come to steady state while taking acquisitions every 60 seconds.  
When the 495/440 ratio reaches steady state, set the acquisition at 20 second intervals. 
enter a comment of "steady state," and take 5 readings.  Record the pH of the solution in 
the chamber (from pH meter) in the solution pH column of the experiment sheet.  
4.  After 5 acquisitions transfer both perfusion lines to the next pH buffer according to the 
following protocols: 
 Protocol 1:  pH 8.6 → pH 8.0 → pH 7.4 → pH 6.8 → pH 6.3 
 Protocol 2:  pH 8.3 → pH 7.7 → pH 7.1 → pH 6.5 
Enter a comment with the pH of the buffer.  There should be a noticeable drop in the 
measured ratio since BCECF is essentially linearly related to pH between pH 6 and 8; 
however, at a pH above 8.0 there may be a minimal change in the measured ratio.  Allow 
the 495/440 ratio to reach steady state.  Set the acquisition at 20 second intervals enter a 
comment of "steady state" and take 5 readings.  During this time, record the pH of the 
solution in the chamber (from the pH meter) in the solution pH column of the experiment 
sheet. Enter a comment indicating the pH the buffer was titrated to.  Write down the pH 
of the buffer in the treatment column of the experiment sheet. 
5.  Repeat for each pH buffer (Figure A2.1). 
6.  Protocol 1 and 2 should both be repeated so that at least one set of data for each pH 
buffer are attained.  The mean of the 495/440 ratio from the 10 selected areas over the 
steady state period for each pH buffer is defined as the ratio at the recorded steady state 
pH (measured by the pH meter).  The calibration should result in a linear relationship 
between the pH and ratio (Figure A2.2) according to the following formula: 
ayratioFluorpH oi /).( −=  
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Figure A2.1.  Time course of 495/440 fluorescence-excitation ratio during exposure to 
high K+-nigericin solutions of different pHs.
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Figure A2.2.  Dependence of normalized fluorescence-excitation ratio on pHi.   
 143
 144
 
APPENDIX 3 
DETERMINATION OF BUFFERING CAPACITY AND BASE FLUX 
 
 
Setting up for an Intrinsic Buffering Capacity Experiment 
1.  Prepare 500 mL of Na+ and HCO3--free Ringers containing varying concentrations of 
NH4Cl (30, 20, 10, 5, and 1) to be used for luminal perfusion.  In these solutions, HCO3- 
is replaced with TES, Na+ is replaced with NMDG+, and the osmolarity of the NH4Cl 
solutions is balanced with NMDG+.  Prepare 1 L of Na+ free TBR (0 mM NH4Cl).  These 
solutions should be gassed with 100% O2 as they are prepared. 
2.  Put NH4Cl Ringers in a 40°C water bath to warm in 100 ml bottles.  Place Na+ free 
TBR in one 100 mL for luminal perfusion and one 250 mL bottle for serosal perfusion.  
Gas these buffer solutions with 100% O2. 
3.  Turn on the dry bath and replace the pH meter calibration solutions.   
4.  Set up for a BCECF microfluorimetry study (see Section A1).   
5.  Serosal Na+ free TBR should contain TTX (0.1 µM) and INDO (1.0 µM). The luminal 
perfusates need INDO only. 
6.  Calibrate the pH meter at 37°C. 
7.  Sacrifice mouse, mount tissue being calibrated mucosal side up (see Section A.1). 
6.  Start the perfusion with Na+ free TBR (serosal).  Put 1 mL of the Na+ Free TBR 
(luminal perfusate) on the luminal side.  Make up DTT in 1 ml Na+ free TBR (100 µM 
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final concentration).  Remove the Na+ free TBR from the top of the tissue by vacuum and 
replace with the DTT solution.  Incubate the tissue for 5 minutes with DTT. 
7.  While the tissue is incubating with DTT, make up the BCECF-AM dye solution. Each 
50 µM tube of dye is rehydrated in 10 µl of Methyl sulfoxide.  Add 2 µl of the BCECF-
AM stock to 1 mL of Na+ free TBR.  
8.  After the 5 minute DTT incubation, apply the dye solution to the luminal surface and 
load the tissue for 10 minutes. 
 
Method for Measuring Intrinsic Buffering Capacity via NH4Cl Prepulse 
1.  Place the chamber under the 40X water immersion objective.  Place the solution in-
line heater probes into the chamber.  Turn on the bottom in-line heater.  Place the cube 
housing in position "o" (open circle) so that there are no filters in the field of view. Pull 
out the filter sliders, turn on the microscope light source to an intensity of ~4.5, and push 
the camera stop in and follow the steps outlined in Section A1 under “Image Acquisition 
and Analysis.” 
2.  When the tissue is finished loading, place the apical perfusion lines in the Na+ free 
TBR.  Start the top vacuum line.  Turn on the solution in-line heaters.  Put the pH 
electrode in the chamber in the top portion as close to the tissue as possible.  Start the 
acquisition. 
3.  Allow the ratio to come to steady state while taking acquisitions every 60 seconds.  
When the 495/440 ratio reaches steady state, set the acquisition at 20 second intervals 
enter a comment of "steady state".  During this time, record the pH of the solution in the 
chamber (from the pH meter) in the solution pH column of the experiment sheet.  
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4.  After 5 acquisitions, transfer the apical perfusion line according to the following 
protocol: 
 Na+ free TBR (0 mM NH4Cl) → 30 mM NH4Cl → 20 mM NH4Cl → 10 mM 
 NH4Cl → 5 mM NH4Cl → 1 mM NH4Cl → 0 mM NH4Cl 
Enter a comment indicating the concentration of NH4Cl.  With 30 mM NH4Cl 
application, there should be a noticeable increase in the ratio as NH3 enters the cell and 
combines with intracellular H+ to form NH4+ and then a slight decrease in ratio can be 
recorded due to the entry (leakage) of NH4+.  Record the pHo at the alkaline peak of the 
trace.  This point will be used to determine the magnitude of the pHi change.  After the 
ratio hits a stable plateau, switch to the 20 mM NH4Cl buffer entering a comment to 
indicate the concentration of NH4Cl.  There should be a noticeable drop in the measured 
ratio since intracellular NH4+ will dissociate into NH3 which exits the cell.  Record the 
pHo at the alkaline peak. 
5.  Repeat for each NH4Cl buffer. 
6.  Several experiments should be conducted in this manner in order to attain 
measurements of βi for a wide range of pHis.  
 
General Principles and Calculations for Determining Intrinsic Buffering Capacity 
1.  Intrinsic buffering capacity (βi) refers to the ability of intrinsic cellular components 
(biochemical and organellar) excluding CO2/HCO3- to buffer changes in pHi.  βi can be 
calculated from the pHi changes produced by exposing the cell to a weak acid or base as 
shown in the following equation: 
 [ ] [ ]
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It is most accurately estimated in cells in which pH-regulatory mechanisms have been 
blocked.  This can be achieved by calculating βi in the absence of extracellular Na+ to 
block Na-dependent pHi regulatory mechanisms (i.e., NHEs). 
2.  Using the ammonia prepulse method, one H+ is formed for every NH4+ reduced to 
NH3-.  Therefore, βi can be calculated by the following equation: 
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3.  Assuming [NH3]i = [NH3]o, [NH4+]i can be calculated using the following 
rearrangement of the Henderson-Hasselbalch equation: 
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where pKa is 8.9 at 37°C, and pHi and pHo are intracellular and extracellular pH 
measurements, respectively. 
4.  By varying the NH4Cl concentration by a known amount (i.e., 30, 20, 10, 5, 1, and 0) 
and measuring pHo (by pH meter) and pHi (by BCECF) at the alkaline peak following 
changes in the concentration of NH4Cl, the ∆[NH4+]i can be calculated. 
5.  By subtracting the pHi measured during of the trace following the NH4Cl 
concentration change from the pHi preceding this change, the βi is determined, which is 
considered to the buffering capacity at about the midpoint of the pHi change.  Values of βi 
are determined at various pHis by varying the amounts of NH4Cl. 
6.  The values of βi calculated at the midpoint of the measured pHi changes are fitted to a 
third-order polynomial according to the following formula: 
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where the values from this fitted curve are used as the values of βi at various pHis (Figure 
A3.1).   
 
Calculating HCO3- Buffering Capacity, Total Buffering Capacity and Flux Rates 
1.  The contribution of CO2/HCO3- to overall buffering in an open system can be 
substantial.  Therefore, for studies performed in the presence of CO2/HCO3-, it is 
necessary to determine HCO3- buffering capacity (βHCO3-). 
2. Assuming an open system with respect to CO2, which is highly permeable through the 
plasma membrane, and that its solubility and pKa value are the same at either side of the 
cell membrane, then: 
βHCO3- = 2.3[HCO3-]i
3.  [HCO3-]i is calculated using the following rearrangement of the Henderson-
Hasselbalch equation: 
  ]03.0log[10]3[ 2 ×+= − pCOHCO ai pKpHi
where pCO2 is 38 mmHg (during gassing with 5% CO2), and pKa is 6.1 at 37ºC. 
4.  The midpoint of the measured pHi changes from the βi are used to determine [HCO3-]i 
and βHCO3- (Figure A3.1). 
5.  The total buffering capacity (βtotal) is then calculated from the following equation: 
  βtotal = βi + βHCO3-
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Figure A3.1.  Plot of intrinsic buffering and HCO3- buffering capacity vs. pHi.
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where the values of βtotal calculated at the midpoint of the measured pHi changes are fitted 
to a inverse third-order polynomial, according to the formula: 
 32
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The values from this fitted curve are used as the values of βtotal, which are accordingly pH 
corrected.   
6.  The rates of pHi change measured during experimental manipulation are converted to 
transmembrane net flux (J) using the equation J = ∆pH/∆t x βtotal, and the βtotal values 
used in the determination of net flux are calculated from the above equation using the 
average pHi during the 90-s period of linear ∆pH/∆t changes. 
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